Panorama of Emergency Medicine

PoEM is an international peer-reviewed (double-blind) independent open access journal dedicated to advancing knowledge and practice in emergency medicine.

ISSN : 3006-0966

Skip to main navigation menu Skip to main content Skip to site footer

Emergency Medicine

5 Items

All Items

  • Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation

    Background
    A clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications.
    Objective
    To review the literature on anticoagulant treatments in CKD, hemodialysis, and transplantation, with particular emphasis on pharmacology, safety, and clinical implementation.
    Methods
    Narrative review of scientific articles from PubMed, EMBASE, and Cochrane databases up to July 2025 inclusive using predefined search strategy. Observational studies, randomized trials, and major guidelines (KDIGO, AHA/ACC, ESC) were included.
    Results
    Despite its widespread use, warfarin has the disadvantage of bleeding and vascular calcification. Apixaban has the best data available among DOACs for use in CKD stage 5. The use of UFH is preferred in dialysis patients due to its reversibility properties. Other new drugs like factor XI inhibitors and LAAO are also very promising.
    Conclusion
    Anticoagulant therapy in patients with renal diseases needs personal risk assessment, proper selection of
    medications, and good management, especially during emergencies.

    Introduction

    An intriguing hemostatic paradox exists in patients with CKD: both thrombotic and hemorrhagic complications arise from uremic changes affecting platelet function, coagulation pathways, endothelial cells, and vascular calcification [1–3]. This challenge is further magnified among ESKD patients on dialysis and in those receiving kidney transplantations, where additional variables — including extracorporeal circuits, perioperative stress, altered pharmacokinetics, and extensive drug-drug interactions attributable to immunosuppressant medications — complicate anticoagulation management [2, 3].
    Within this context, this review critically analyzes the current literature on anticoagulation therapy in patients with CKD, on dialysis, and after kidney transplantation. This topic is clinically significant due to the increasing incidence of chronic kidney disease throughout the world and the increased use of DOACs, making an evidence-based strategy critical for efficacy and reduced bleeding complications [4].

    Epidemiology

    Patients with CKD face an established, progressively increased susceptibility to both thromboembolic and hemorrhagic events, including venous thromboembolism (VTE) and atrial fibrillation (AF). The degree of this susceptibility is proportionate to the severity of kidney function impairment and the impact of coexisting conditions like diabetes and high blood pressure [2–4]. The prothrombotic state is accompanied by a concurrent propensity for bleeding complications, arising from hemostatic abnormalities intrinsic to CKD. Patients with end-stage renal disease (ESKD) on dialysis face additional thrombotic and hemorrhagic risks related to frequent vascular access, extracorporeal circulation, dialysis-related anticoagulation, and uremia-induced platelet dysfunction [3–6]. Kidney transplant recipients constitute a further high-risk subgroup, in whom surgical trauma and ongoing immunosuppressive therapy contribute to an elevated early post-transplant risk of VTE [2, 7].

    Methods

    This is a narrative review. It does not aim to conduct a systematic review; rather, it synthesizes available scientific evidence on anticoagulant therapy in patients with CKD, ESKD, dialysis, and kidney transplantation.
    The literature search was conducted across PubMed, EMBASE, and the Cochrane Library from database inception through July 2025. Search terms were combined using Boolean operators (AND/OR) and included: "chronic kidney disease,"
    "end-stage renal disease," "dialysis," "kidney transplant," "anticoagulation," "warfarin," "direct oral anticoagulants (DOACs)," "bleeding," "thrombosis," and "stroke."
    Studies considered eligible comprised randomized controlled trials (RCTs) as well as observational, cohort studies, meta-analyses, and major international clinical practice guidelines (KDIGO, AHA/ACC, and ESC). Case reports, narrative commentaries without original data, and non-English publications were excluded.
    Study selection was carried out in two phases: a preliminary review of titles and abstracts, followed by full-text assessment for relevance to the pharmacokinetics and clinical use of anticoagulants in CKD, dialysis, and transplantation populations. Given the known exclusion of patients with an estimated glomerular filtration rate (eGFR) <30 mL/min from most RCTs, the evidence base was anticipated to rely predominantly on observational studies and post-hoc subgroup analyses — a finding that was confirmed.
    Qualitative data synthesis was performed through comparison of efficacy, bleeding risk, pharmacokinetics, and clinical applicability in both chronic and emergency settings.

    Pharmacokinetic considerations

    Renal dysfunction significantly impacts drug distribution, protein binding, and metabolism; hence, thereby influencing anticoagulant pharmacodynamics. DOACs vary widely in their reliance on renal elimination; dabigatran is highly dependent, being primarily eliminated by the kidneys [4, 11]. For ESKD patients, available treatment options are restricted, as only a few anticoagulants — including warfarin and apixaban — have received FDA approval in this population [10–13]. Significant drug-drug interactions are also common in kidney transplant patients owing to concomitant use of immunosuppressants [7].

    Results: Evidence Synthesis by Anticoagulant Class

    Vitamin K Antagonists
    Warfarin remains the most widely used anticoagulant in CKD and ESKD (Table 1) owing to its long clinical track record and reversibility. However, its use is limited by a narrow therapeutic index, frequent drug and food interactions, and increased risks of bleeding and vascular calcification, including calciphylaxis [8, 9]. Observational studies suggest no consistent reduction in stroke risk in dialysis populations, with a concurrent increase in major bleeding compared with non-CKD cohorts.

    Direct Oral Anticoagulants (DOACs)
    DOACs offer more predictable pharmacokinetics and do not require routine monitoring compared with warfarin, although pharmacokinetic variation among agents is notable (Table 2). Among DOACs, apixaban has the largest body of clinical evidence in patients with severe CKD and those on dialysis [10–14]. Observational studies consistently indicate that apixaban reduces the incidence of major bleeding and provides similar or superior antithrombotic efficacy compared with warfarin.
    By contrast, dabigatran is primarily excreted renally, leading to drug accumulation in CKD; its use is therefore generally not recommended in severe CKD in this population. In addition, rivaroxaban and edoxaban have moderate renal clearance, and data on their use in ESKD patients remain limited.

    Heparins and LMWH
    Nevertheless, UFH remains the gold standard for anticoagulation during hemodialysis because of its short half-life and completely reversible action. While LMWHs exhibit superior pharmacokinetic behavior, their use should be strictly controlled since there is a possibility of their accumulation in patients with renal insufficiency [5, 6]. The pharmacology of these medications is described in Table 3.

    Emerging Therapies
    Novel anticoagulant strategies are summarized in Table 4. Antiplatelets may be used adjunctively in select transplant patients but increase bleeding risk [16]. Novel strategies such as Factor XI inhibitors and left atrial appendage closure are promising [25, 26].

    Population-specific considerations

    For patients undergoing hemodialysis, there is a need for achieving a balance between the timing of doses and the risk of vascular access complications as well as clot formation within the dialysis machine circuit. Peritoneal dialysis is relatively safe regarding the pharmacokinetic stability and decreased bleeding tendency. However, evidence supporting this remains limited. For patients receiving a kidney transplant, there are notable adverse drug interactions that may affect the pharmacologic efficacy of the drug, especially with regards to CYP3A4 and P-glycoprotein mechanisms [7, 16].

    Discussion

    The management of anticoagulation therapy for those with CKD, dialysis, and kidney transplantation represents one of the most complex tasks owing to the risks of developing both thrombosis and bleeding. Research concerning this issue shows that there is a high degree of heterogeneity, while the majority of studies conducted are observational. Few randomized controlled trials have been conducted for advanced renal dysfunction. As far as warfarin is concerned, it is one of the most researched anticoagulants in CKD patients, although its application poses risks including increased chances of bleeding, need for regular monitoring, and vascular calcification. Among the DOACs, apixaban appears to be quite promising. Evidence grading across therapies highlights that high‑quality RCT data are restricted to general atrial fibrillation populations with minimal inclusion of advanced CKD patients, moderate evidence stems from post‑hoc or subgroup analyses of DOAC trials that remain underpowered for renal endpoints, and low to moderate evidence is dominated by observational studies, especially for apixaban, which consistently signals reduced bleeding compared with warfarin. Expert opinion and guideline‑based recommendations reflect this uncertainty: KDIGO emphasizes insufficient evidence, whereas AHA/ACC and ESC guidelines cautiously support DOAC use in selected CKD patients [15–17]. With regards to the field of emergency medicine, the proper identification of the anticoagulant in question along with its reversal become particularly crucial in the situation of either bleeding or urgent procedures, which might involve the utilization of vitamin K and PCC as treatment strategies in managing bleeding due to warfarin, idarucizumab as a treatment strategy aimed at reversing the effects of dabigatran, and andexanet alfa as a treatment strategy used to reverse the action of factor Xa inhibitors, although, only with the modest efficiency of hemodialysis in the latter case and without having any impact on most of the factor Xa inhibitors. There is no applicability of the findings obtained from the existing research studies due to several factors: the lack of data obtained within the framework of randomized trials, the involvement of individuals who have an estimated GFR below 30 mL/min, heterogeneous study designs, the insufficient representation of patients with transplants, and lack of consistency in defining the endpoint. In summary, although apixaban has been shown to be the safest of all anticoagulants through observational studies and heparin unfractionated still plays an important role in dialysis, there is still no certainty about which approach is superior in patients with advanced stages of CKD. Some of the areas that remain challenging and require further research include adequately powered RCTs among dialysis and transplanted patients [6, 17], improvement of risk stratification models accounting for specific uremia-related factors [17], and development of more tolerable medications including factor XI inhibitors [17]. Possible strategies to improve anticoagulation therapy among this population include increasing the availability of reversal agents for DOACs [13] and validation of other non-pharmacologic methods like left atrial appendage closure (LAAC) [18].

    Recent Developments in Anticoagulation in CKD (2022–2025)
    Recent developments (2022–2025) have contributed substantially to the scientific basis of anticoagulation in patients with chronic kidney disease (CKD), especially in dialysis, transplantation, and non-pharmacologic approaches.

    Use of DOACs in Dialysis Populations
    New insights gained from current meta-analyses and cohort studies show that DOACs, specifically apixaban, might offer a better safety profile when compared with VKAs in dialysis patients, mainly based on a reduced bleeding risk without compromising thromboembolism prevention [6, 13]. New systematic reviews from clinical trials and observational studies demonstrate that DOACs can decrease bleeding risk in dialysis patients, despite the limited number of participants and study heterogeneity [6]. Nonetheless, guidelines still recommend caution in view of the lack of large-scale randomized clinical trials in ESKD populations [17].

    Factor XI Inhibitors (Newer Anticoagulants)
    Newer factor XI inhibitors, among which there is abelacimab and milvexian, represent a novel anticoagulant class aiming to improve thromboprotection without increasing bleeding risks. Phase II and ongoing Phase III clinical studies indicate that the selective targeting of factor XI may be more beneficial for high-bleeding-risk individuals, such as CKD patients, owing to the minimal dependence on renal elimination [25]. However, at present, there is not enough randomized trial data about the use of factor XI inhibitors among dialysis patients.

    Left Atrial Appendage OccCClusion (LAAO)
    The latest literature (2022–2025) highlights new evidence regarding the potential benefits of using left atrial appendage occlusion (LAAO) as a non-medication therapy modality for stroke prevention among atrial fibrillation patients who suffer from CKD and ESKD. According to modern findings, LAAO has been proven to have some advantages over long-term oral anticoagulation therapy concerning both decreased mortality rate and lower major bleeding rates [18, 26]. Moreover, observational registries in dialysis patients confirm satisfactory procedural safety, with no increased hemorrhagic events despite limited randomized comparison with DOACs [6, 26].

    Anticoagulation in Kidney Transplant Recipients
    In recent years, new research has shown the difficulty of anticoagulation among kidney transplant recipients, where interactions between drugs such as calcineurin inhibitors and mTOR inhibitors play a role in the pharmacokinetics of anticoagulants. According to recently updated cohort studies (2023–2025), apixaban and rivaroxaban can be safely administered among specific transplant patients, despite possible interactions with cytochrome P450 3A4 and P-glycoprotein [8]. While observational studies show the relative safety of DOACs among transplant recipients, more evidence is still needed from randomized controlled trials. Warfarin is thus a common choice for such patients [7].

    Integrated Interpretation of Recent Evidence
    As a whole, findings reported over the years 2022–2025 have supported the notion that there has been a relatively slow move toward increasing yet prudent administration of apixaban in dialysis patients, emergence of factor XI inhibitors as future safe anticoagulants, and further confirmation of LAAO as an effective approach in high-risk CKD patients. Simultaneously, the use of DOACs in renal transplant patients has become more prevalent but still highly restricted owing to various safety issues. Nevertheless, even with such advancements, it should be noted that most of the available evidence continues to come from observational studies, calling for randomized controlled trials involving advanced CKD, dialysis, and transplant patients.

    Limitations

    The current review is limited by its narrative approach and heterogeneous sources of information. The high number of observational studies and subgroup analyses increases the risk of bias and decreases the generalizability of findings. Moreover, the majority of randomized clinical trials do not include patients with advanced kidney failure, which limits the level of the obtained evidence. The lack of information among kidney transplant recipients is another limitation.

    Future directions

    Further studies should focus on RCTs involving dialysis and transplantation patients [6, 17]. The creation of new CKD-risk stratification models will be essential in achieving an optimal balance between thromboembolism and hemorrhagic complications [17]. New anticoagulants, especially that inhibiting factor XI, can be promising for future clinical practice [17]. Finally, the development of DOAC reversal agents and novel treatment modalities, such as LAA occlusion, needs to be considered [13, 18]. Future AI-based methods might become indispensable for personalized anticoagulation.

    Conclusion

    Despite the concurrent presence of a heightened risk for thrombosis and bleeding, anticoagulation therapy in CKD patients, dialysis, and kidney transplantation remains challenging. In clinical practice, warfarin is still largely used, while UFH is the preferred choice of anticoagulant in dialysis patients. When considering the DOACs, apixaban appears to have a favorable safety profile based on observational data as long as dosage modification is considered. In conclusion, for an ideal anticoagulation therapy, risk-benefit analysis, monitoring, and choosing the appropriate medication are all essential. More research studies using randomized controlled trials are recommended for the future.

    Author Contributions
    AJZ conceived, drafted, critically reviewed and edited the manuscript. The author approved the final version.

    Declarations
    Ethical Approval
    This review is based entirely on previously published studies and publicly available data. No individual patient data were collected or analyzed. Institutional review board approval was not required.
    Informed Consent
    No new human participants were involved in this review article; informed consent was not required.
    Animal Research
    This article does not contain any studies with animals performed by the author.
    Conflict of Interest
    The author declare that he has no conflicts of interest related to this work.
    Funding
    This research received no external funding.
    Data Availability
    All data underlying this article are derived from the published literature cited herein. No new datasets were generated or analyzed by the author.

    References

    1. Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022 Apr;12(1):7–11. https://doi.org/10.1016/j.kisu.2021.11.003
    2. Waddy SP, Solomon AJ, Becerra AZ, Ward JB, Chan KE, Fwu CW, et al. Racial/Ethnic Disparities in Atrial Fibrillation Treatment and Outcomes among Dialysis Patients in the United States. J Am Soc Nephrol. 2020 Mar;31(3):637-649. https://doi.org/10.1681/ASN.2019050543
    3. Aursulesei V, Costache II. Anticoagulation in chronic kidney disease: from guidelines to clinical practice. Clin Cardiol. 2019;42(8):774–782. https://doi.org/10.1002/clc.23196
    4. Chan KE, Giugliano RP, Patel MR, Abramson S, Jardine M, Zhao S, et al. Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF. J Am Coll Cardiol. 2016 Jun 21;67(24):2888–99. https://doi.org/10.1016/j.jacc.2016.02.082
    5. Kessler M, Moureau F, Nguyen P. Anticoagulation in chronic hemodialysis: progress toward an optimal approach. Semin Dial. 2015;28(5):474–489. https://doi.org/10.1111/sdi.12380
    6. Parul F, Ratnani T, Subramani S, Bhatia H, Ashmawy RE, Nair N, et al. Anticoagulation in Patients with End-Stage Renal Disease: A Critical Review. Healthcare. 2025; 13(12):1373. https://doi.org/10.3390/healthcare13121373
    7. Santoro F, Casanova A, Simone S, Alfieri C, Falcone A, Dello Strologo A, et al. Immunosuppressive therapy and oral anticoagulation in kidney transplant recipients: Direct oral anticoagulants versus vitamin-k antagonists. Eur J Intern Med. 2024 Jan; 119:71–77. https://doi.org/10.1016/j.ejim.2023.08.003
    8. Wen MS, Lee MT. Warfarin Pharmacogenetics: New Life for an Old Drug. Acta Cardiol Sin. 2013 May;29(3):235–42.
    9. Wang X, Peng L, Ma J, Zhang L, Liu J. Warfarin-Induced Calcification: Potential Prevention and Treatment Strategies. Rev Cardiovasc Med. 2022 Sep 16;23(9):322. https://doi.org/10.31083/j.rcm2309322
    10. Siontis KC, Zhang X, Eckard A, Bhave N, Schaubel DE, He K, et al. Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States. Circulation. 2018 Oct 9;138(15):1519–1529. https://doi.org/10.1161/circulationaha.118.035418
    11. Mandt SR, Thadathil N, Klem C, Russ C, McNamee PL, Stigge K, Cheng D. Apixaban Use in Patients with Kidney Impairment: A Review of Pharmacokinetic, Interventional, and Observational Study Data. Am J Cardiovasc Drugs. 2024 Sep;24(5):603–624. https://doi.org/10.1007/s40256-024-00664-2
    12. Moore M, Vizcaino K, Ewing JA, St Ville M. Efficacy and safety of apixaban compared to warfarin for nonvalvular atrial fibrillation in end-stage renal disease on hemodialysis. J Am Pharm Assoc (2003). 2024 Mar–Apr;64(2):457–462. https://doi.org/10.1016/j.japh.2023.12.020
    13. AlTurki A, Marafi M, Dawas A, Joza J, Proietti R, Russo Vet al. Meta-analysis evaluating apixaban in patients with atrial fibrillation and end-stage renal disease requiring dialysis. J Arrhythm. 2024 May 6;40(3):440–447. https://doi.org/10.1002/joa3.13051
    14. El Nekidy W, Abidi E, Nabil S, Kendakji S, Ali M, Aburuz S, et al. The Safety and Effectiveness of Apixaban in Patients with End-Stage Kidney Disease on Dialysis: A Retrospective Observational Study. J Clin Med. 2024 Feb 27;13(5):1351. https://doi.org/10.3390/jcm13051351
    15. Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 2;149(1):e1–e156. https://doi.org/10.1161/CIR.0000000000001193
    16. Rienstra M, Tzeis S, Bunting KV, Caso V, Crijns HJGM, De Potter TJR, et al. Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects. Europace. 2024 Dec 3;26(12):euae298. https://doi.org/10.1093/europace/euae298
    17. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2024 clinical practice guideline for CKD evaluation and management. Kidney Int. 2024;105(Suppl 1): S1–S150. https://doi.org/10.1016/j.kint.2023.10.018
    18. Lange NW, Muir J, Salerno DM. Direct Oral Anticoagulants in Patients With ESRD and Kidney Transplantation. Kidney Int Rep. 2024 Oct 28;10(1):40–53. https://doi.org/10.1016/j.ekir.2024.10.016
    19. Weir MR, Ashton V, Moore KT, Shrivastava S, Peterson ED, Ammann EM. Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease. Am Heart J. 2020 May;223:3–11. https://doi.org/10.1016/j.ahj.2020.01.010
    20. U.S. Food and Drug Administration. XARELTO (rivaroxaban) Prescribing Information. Updated 2025. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022406s044,215859s005lbl.pdf
    21. U.S. Food and Drug Administration. Pradaxa (dabigatran) prescribing information. Updated 2025. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022512s049lbl.pdf
    22. U.S. Food and Drug Administration. Savaysa (edoxaban) prescribing information. Updated 2025. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/206316s015lbl.pdf
    23. Shoeb M, Fang MC. Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis. 2013 Apr;35(3):312-9. https://doi.org/10.1007/s11239-013-0899-7
    24. Alonso-Escalante JC, Machado L, Tabar KR, Tindall R, Thai N, Uemura T. Is Continuing Anticoagulation or Antiplatelet Therapy Safe Prior to Kidney Transplantation? Ann Transplant. 2021 Sep 28;26:e931648. https://doi.org/10.12659/aot.931648
    25. Calderon Martinez E, Sanchez Cruz C, Diarte Acosta EY, Aguirre Cano DA, Espinosa AM, Othón Martínez D, et al. Efficacy and safety of novel anticoagulant therapies in patients with chronic kidney disease-a systematic review and meta-analysis. J Nephrol. 2025 Jan;38(1):111–126. https://doi.org/10.1007/s40620-024-02130-3
    26. Maarse M, Seiffge DJ, Werring DJ, Boersma LVA, STR-OAC LAAO Group, RAF, RAF-DOAC, CROMIS-2, SAMURAI, NOACISP, Erlangen Registry, and Verona Registry. Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation. JAMA Neurol. 2024;81(11):1150–1158. https://doi.org/10.1001/jamaneurol.2024.2882
    27. Bansal N, Xie D, Tao K, Chen J, Deo R, Horwitz E, et al. Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1189-1196

  • Suggestions for the Study of Ethics of Simulation in Healthcare

    Simulation can be used in healthcare education to provide learners with the opportunity to develop the knowledge and skills needed to manage complex situations and provide patient care, however one aspect easily overlooked and which has many ramifications, is that of ethical practice.

    Simulation-based education is a moral and ethical imperative. “Never the first time on the patient!” is displayed at the entrance of some clinical simulation centres, but the rest of the ethical obligations, besides the professional code of ethics, are either not mentioned or only sporadically.

    By using an interpretive framework based upon the 4 bioethics principles used for patients (autonomy, beneficence, nonmaleficence, and distributive justice), we propose, as a conceptual framework, an analysis on the stakeholders of simulation-based education (SBE) - educators, learners, and simulated participants - to broaden and explore in depth the conventional views of ethics in simulation. This article also discusses specific features in simulation which sometimes pose an ethical dilemma such as facing simulated death, breaking bad news, research, the use of biological tissue, teaching ethics, and computer simulation.

    This proposal to explore ethics in healthcare simulation is intended to stimulate reflection rather than serve as a model seeking external validation.

    Foreword

    Before embarking on exploring ethics in healthcare simulation as a conceptual framework, we believe it is important to clarify the relationship between a practice, its ethical aspects, and its legal aspects. The relationship between biomedical practice, ethics, and legislation is closely tied to a society’s historical, cultural, political, and religious context [1, 2]. More specifically, the relationship between ethics and the law regarding a given action evolves according to dynamics shaped by this context. Two examples related to simulation illustrate this point:

    1. In France, donating a body to science has been legal since 1953, provided there is prior consent from the donor and that it is done with due respect for the body [3]. In 2019, a scandal was revealed by the press at an anatomy laboratory at Paris-Descartes University involving the discovery of inappropriately managed dismembered bodies and scattered anatomical parts [4]. Yet it was legal and must have been practiced in other laboratories for years. The fact that there were also illegal practices (poor hygiene, removal of jewelry from corpses) triggered an investigation and revealed a set of practices that had become unethical. This, in addition to disciplinary action against an individual, was deemed unethical (in light of the evolving concept of due respect for the body since 1953) and prompted the government to put a new law in place to better regulate this practice [5]. Thus, French law is the product of what occurs within the context of French society and may or may not correspond to practices in other countries. It is neither transferable nor generalizable. It may inspire other communities to amend their legislation in accordance with their historical, cultural, political, and religious contexts. In this case, the practice of donating one’s body to science was originally legal and ethical; however, due to illegal abuses, it aroused appropriately founded concerns and came to be viewed as unethical in its current form, prompting lawmakers to strengthen the law to align with bioethical principles as perceived by the French public in 2022 [6].

    2. As of today, in France as elsewhere, the use of Artificial Intelligence (AI) is legal (or rather, not illegal) and ethical in simulation. However, certain developments in AI may be viewed as risks that challenge bioethical principles. In such situations, a country’s legislation might need to change to legally regulate the use of AI, for example, if there is a potential harm to individuals. In other countries, this use could continue unhindered. Finally, for certain communities, although legal, the use of AI should comply with a code of ethics established by one or more medical societies. We thus see the importance of the sociological context regarding the tensions between legislation and ethics that may arise over time, and the dynamics that enable their resolution. For example, would it be ethical to have an AI entity conduct a debriefing of a healthcare professional following a simulation-based activity in order to determine whether they can return to work after an extended sick leave? For now, this is neither mandatory nor illegal, but is it ethical? [7].
    Consequently, the approach we present here is closely tied to the sociological context of our country of origin and, therefore, to the evolution of its legislation. This is inevitable in any human community.

    Introduction

    The rapid and universal deployment of simulation in healthcare for educational or system testing or redesign purposes raises the question of its limits. Technological limits seem ephemeral, falling one after the other as years go by. However, simulation in healthcare, like any human activity, has ethical limits that codify and modulate the use of these technological advances.
    Here we propose a conceptual framework that allows us to broaden and explore in depth the conventional view of ethics in simulation, which is tied to the principle of beneficence toward the patient (“never the first time on the patient”). In fact, the rest of the ethical obligations besides the professional code of ethics, are either not mentioned or are mentioned only sporadically.
    Because simulation in healthcare education is an activity aiming to improve patient care, we have chosen to use the “bioethical principles” tool – usually reserved to patients or research participants – to describe these limits and apply them to activities concerning people who are upstream or downstream of the use of simulation as an educational approach, taking into account the different people who may use it, and highlighting the conflicts that may exist between certain bioethical principles in particular situations. Therefore, the objective of this article is to provide a broader and more detailed perspective on ethics in simulation using the framework provided by bioethical principles. It includes not only patients but also all stakeholders (educators, learners, and simulated participants) and to examine several specific simulation situations. This proposal to explore ethics through healthcare simulation is intended to stimulate reflection rather than serve as a model seeking external validation outside of its sociological context.
    This article is based on the simulation in healthcare good practice guide published in March 2024 by the French National Healthcare Authority [8].

    Simulation-based education is an ethical and moral imperative

    The benefits of simulation-based learning in healthcare have been demonstrated [9, 10], and like any human activity, it has both ethical and professional requirements and limits. The four principles of bioethics are autonomy, beneficence, non-maleficence, and distributive justice [11]. Simulation in healthcare education is an ethical and moral imperative for healthcare professionals and trainees with respects to their patients, as Ziv et al. put it over twenty years ago [12]. Simulation therefore begins with an important moral commitment: ‘’We must do the best we can to keep patients safe while training the next generation of clinicians and retraining current clinicians so that they are kept up to date. If we can introduce clinicians to patients when these clinicians have more “experience” with quasi-patients of a wide variety, we lessen the chances that vulnerable patients will be harmed. Ethics is not an add-on to simulation; an ethical claim drives the practices of simulation themselves’’ [13].
    Furthermore, simulation has an epistemic role in that it can transform theoretical knowledge into practical know-how, enabling the universal application of international recommendations for patient wellbeing [14, 15]. Simulation users as educators must therefore endorse a professional ethics and have the responsibility of training all healthcare professionals at the highest level of performance possible.

    Ethics and simulation-based education

    The principles of bioethics can also be extended to everything patient related. If the care provided to patients appears to be the primary concern - the ethics of simulation-based education (SBE) for the patient - so too is the learning of the healthcare professionals who will deliver this care. Indeed, better learning is the key to better care [16]. This objective can also include the ethics of those involved in the educational process. In this way, we can define the ethical aim and content of the various bioethical principles applied to these people and which we have summarised in Table 1.

    For patients
    The ethical aim for patients is that simulation should help them receive the best possible care according to current evidenced-based practice.

    Autonomy, the ability to decide for oneself, was reinforced by the French Law of March 4, 2002 [17]. It is essentially based on the principle of information and consent. In the domain of healthcare education, it can refer to informing patients that the training of healthcare professionals involves the use of simulation. This can be done through disclosure in the patients’ welcome booklet or on information boards, but also orally before a procedure is performed, for example. It has been reported that patients preferred to have a procedure performed by a simulation-trained professional rather than by a professional who has not been trained using simulation [18]. This also includes information on the fact that procedures performed by a junior simulation-trained clinician will be supervised by a more senior clinician, with the inevitable patient right of refusal without prejudice. Another aspect relates to the commercial independence of prescriptions (medical devices and drugs) made for the patient. In the case of in-situ simulation in a real clinical setting, it is imperative to inform patients on the unit that there are two teams: a care team and a simulation training team. The latter may cause some noise and temporary inconvenience, but it should never to the detriment of patient care. Once the patient has been given clear, fair information in a language they can understand, written consent for the treatment should be obtained.

    The principle of beneficence means looking for elements of the simulation that are intended to benefit the patient. The Kirkpatrick pyramid [19] can be used to classify them into levels.
    Simulation-based training aims to benefit the patient by improving the performance level of healthcare professionals (Kirkpatrick level 2 = K2), changing professional practices and increasing compliance with recommendations (K3). Simulation benefits patients by reducing morbidity (complications, worsening, etc.) and mortality in the rare studies that have reached K4 [20, 21]. Simulation has also been shown to reduce healthcare costs [20, 22], which can be considered as level 5 of the Kirkpatrick's pyramid (K5). The arguments are so numerous that this led to the saying “Never the first time on the patient” being displayed at the entrance of some clinical simulation centres [23].
    The principle of non-maleficence corresponds to tracking down conflicts of interest that would lead to harm for the patient. For example, excessive development of in-situ simulation at the expense of clinical timetables or human resources for patient care would be a case of maleficence. Similarly, the risk of mixing of simulated drugs and medical devices with those dedicated to real patients in a clinical unit where in-situ simulation is taking place, would also be a case of maleficence [24]. The same would apply if a patient room used for in-situ simulation was not cleaned before a patient was admitted. There could be unfortunate consequences in terms of iatrogenic and nosocomial infections.
    Applying the principle of distributive justice means, on the one hand, ensuring that all patients can benefit from healthcare professionals trained using SBE, and, on the other hand, that the care delivered by trained staff is provided to all patients, regardless of resources, religion, opinion, ethnicity, age or gender... irrespective of the type of service, the status of the staff and their working hours (day or night shift), 24 hours a day, 7 days per week.

    For educators
    Immersive scenario-based simulation probably provides the best possible learning experience in the field of health to learners so that they develop better skills, provide more humanistic care, avoid errors and adverse events, and minimize their consequences, and thus make medical practice safer [25]. As such, educators should have for ethical aim to foster the use of SBE at every opportunity.

    Autonomy. A first obstacle to this freedom would be resistance to the ''simulation'' concept by decision-maker (hospitals, universities, professional and accreditation bodies...). In this respect, it is interesting to go back to the beginnings of simulation in aeronautics, which encountered this same obstacle. As McLoed said in the late 1960s: ‘’I expressed my growing concern for the future of mankind and my intention of applying the technology of simulation to help alleviate the problems of society. It hasn't been easy. Among other things I have felt grave concern over the lack of acceptance of the results of modelling and simulation. In a time of increasing complexity of life, when decision-makers need all the help they can get, the very powerful tool of modelling is sometimes not used, or is misused, or the results of modelling, once obtained, are not acted upon’’ [26]. These words are still relevant today in the world of healthcare. This ethical obstacle has largely been overcome by the inclusion of SBE in initial and continuing training programmes, and other governmental or professional initiatives [27].
    Secondly, autonomy could correspond to the freedom to initiate SBE programmes without being dependent on commercial companies. However, freedom of choice in the acquisition of simulation equipment depends on sources of funding, and therefore on institutional, regional, and national political powers to supply these resources. Otherwise, these same institutions must guarantee and enforce ethical rules with regards to companies. These rules are now well established and guarantee the educators’ autonomy in the practice of healthcare simulation. Another problem that can hamper the freedom of the simulation educator is the growing competition between multiple companies, making this choice inevitably subject to commercial pressures (discounts on the purchase of several models, addition of complimentary devices in the event of an expensive purchase...). Paradoxically, the absence of freedom of choice linked to a governmental decision can make it possible to free oneself from financial influence struggles. An example is the recent purchase by each medical school in France of the simulation models required for Objective Structured Clinical Examinations according to a list prescribed by a national steering committee. This underscores the importance of drafting and disseminating recommendations on pedagogical efficiency, which should prevail over any costly investments in the field of healthcare SBE.
    One might think that the beneficence for the educator would be the ease with which they could deliver courses without institutional or financial obstacles, and that these courses could clearly benefit learners. This largely depends on the “simulation culture” of a country or region, and on the way in which legislative texts related to the use of SBE for healthcare professionals are applied, as well as on the acceptance and integration of simulation education concepts and tools by those involved.

    Non-maleficence. All too often, the use of simulation as a learning approach in the healthcare professions involves resolving professional practice conflicts. The primary conflict in many countries, is the educator's personal time dedicated to SBE when they have a full-time clinical role. This time is still often the educator's personal time, not identified or accounted for by the employer. Such personal time commitment initially made it possible, and is still an enabler to launch SBE activities in many institutions, but under no circumstances can it be made permanent, at the risk of undermining motivation. The second conflict concerns in-situ simulation. This often takes place in emergency care units and must be balanced against the care of real patients [24]. Limited staff resources hamper the development of in-situ simulation, which can only take place when the patient flow remains reasonable.
    Applying the principle of distributive justice to simulation educators means talking about access to SBE for educators in relation to their own training. This is largely dependent on country, culture, and mentality. Two examples illustrate this point. The first is the assistance in equipment and training provided by volunteer international educators in 2013 from the International Paediatric Simulation Society to the only paediatrician in Malawi to improve infant care in the country [28]. The second example is the beneficial action of the programme “Helping Babies Breathe” carried out in 2016 by the American Academy of Paediatrics, supported by the United Nations High Commissioner for Refugees, and sponsored by the Laerdal Foundation in Ghana, Rwanda, Indonesia, and Nepal. This involved the supply of low-cost newborn manikins with a training programme, teaching material, training of trainers, evaluators for initial and remote monitoring over several years, resulting in a significant reduction in neonatal mortality [29]. Another issue in some countries is the impossibility for healthcare professionals to have access to anatomical subjects for SBE purposes due to religious barriers. For example, Libyan surgeons have twice come to France to train on the SimLife model [30]. An alternative approach is the use of synthetic or digital simulation tools as they allow for the rapid dissemination of SBE, requiring only a power outlet and internet access.

    Other principles
    For educators, it is important to add two other aspects of ethics that cannot be included in bioethics principles: professional ethics and the ethics of responsibility.
    Professional ethics refers to procedural ethics including all the rules of good SBE practice [31], while keeping learners safe, preventing errors and facilitating learning, as described as imperatives in the Society of Simulation in Healthcare's Code of Ethics [13, 32]. Furthermore, SBE also involves training in the practice of debriefing so that it is relevant and non-offensive [33]. This benevolence towards learners is part of the rules of healthcare simulation and attempts to mirror the principle of beneficence that should guide healthcare professionals towards doing their best for their patients. It is an essential professional ethics principle, and this notion comes close to the ethics of virtue by “doing good” for the patient and for the learner [34], but also anchoring this ability in the absolute necessity of evaluating the performance of learners' actions and behaviours.
    The idea of an ethic of responsibility for the educator is that they must do everything possible to obtain results corresponding to the K2, K3, and even K4 levels of Kirkpatrick's pyramid [35, 36]. The ethical importance of evaluation in SBE can be seen here, as it is the only way to demonstrate progress in learning and performance.

    For learners
    The ethical aim for learners in a simulation programme is to benefit from the best possible education to develop their knowledge and competence to improve patient care.
    Autonomy. In initial training, like in continuing professional development, the validation of SBE has almost become an obligation [37]. Learners must be briefed concerning any SBE activity they get involved in and give their consent [38, 39]. Inappropriate briefing or consent increases the risk of a difficult debriefing which could impact the learning process [40, 41].
    Information within the briefing must include various elements:
    - Educators’ compliance with the Simulation Code of Ethics [32].
    - Context of the activity (pre-briefing and orientation): Review of prerequisite learning, presenting ground rules (confidentiality, benevolence, respect, neutrality, mutual trust), and type of activity (scheduled/unannounced, summative/formative) [36]. It is also important to help learners familiarise with the environment (centre or in-situ, peri-situ) and the medical and simulation equipment [42]. If there is a formative assessment of performance during the scenario, it is only for guiding the debriefing and it will not be transmitted to anyone in the clinical setting.
    - Briefing: Providing an introduction to the scenario; explaining that it may include specific critical procedures with a causal link to the survival of the “patient” [42].
    - Limitations of the simulation experience: Possible differences from practice in a clinical unit and potential technological issues with the manikin [43], up to the point where a scenario may have to continue in a verbal form.
    - Need for engagement – with the ‘’as if’’ concept so learners suspend disbelief about aspects that lack realism [43-45]. Suspension of disbelief becomes the core of the efficiency of SBE and is agreed upon as part of a fiction contract established with the learners [46].
    - Awakening to the knowledge of possible “intruders”. Unexpected external events may be planned in the scenario to approximate reality such as the visit of angry relatives, voluntary malfunction of a device, unavoidable death of the manikin, etc. In this case, the information is limited to: “You are required to deal with the present case as you would in real life”. Other elements independent of the scenario's story must also be given to learners, so that they can freely accept the simulation without feeling prejudiced [47].
    - Use of personal data: give full details of how any video recording of the activity or learners' computerized performance data collected by any type of sensors will be used.
    - Independence from any commercial interest: There should be no passive commercial seeding of learners, fraudulent reuse of digital data (mailing lists...), devices, healthcare services in all their forms, direct or indirect (48-50).
    - Assurance of the ethical aspect of the simulation model: for a simulated patient: acceptance of the role, irrespective of their age (51); for the use of cadavers: compliance with the rules governing the donation of the body to science (5); for an animal anatomical part: compliance with ethical rules related to animals (52, 53).

    For learners, the principle of beneficence amounts to asserting that SBE provides a benefit, and in the case of normative evaluation, training validation or recertification (54). This benefit is based on the rules of SBE, especially benevolence.
    - The scenario should be adapted to the learners' level so as not to set them up for failure but just to challenge them enough so they operate at the edge of their comfort zone whereby they may be expected to make mistakes without being completely overwhelmed (14, 55).

    - The realism, which corresponds to the fidelity of the “simulation” experience as perceived by the learners (environment, model, and scenario), should match the clinical reality required to achieve the activity’s learning objectives whilst also providing learner satisfaction (K1) (36, 43). This may also be linked to the possibility of interacting with the model: simulated patient, manikin, Virtual Reality simulator, cadaver, etc. (56-58). These elements (environment, model, scenario) combined with psychological fidelity (contextualization of the scenario and realistic and immersive engagement of the learners in the activity), constitute the 4 elements of simulation fidelity, which corresponds to the highest level of realism (43). This guarantees that learners are exposed to a valid SBE experience.
    - The increase in knowledge, know-how, interpersonal skills, as well as self-confidence and a sense of personal efficacy, corresponding to level K2 (36).
    - The debriefing should be of quality, respectful, non-offensive, and relevant. This is dependent on the training of the educators so they develop optimal debriefing skills (59).

    Respecting the principle of non-maleficence means avoiding any harm to learners or ensuring that any potential harm is associated with a positive benefit/risk ratio. This is about not “tricking” learners with bad intentions, nor purposefully provoking negative emotions. The feeling of being deceived can come from the scenario itself, from simulated participants, or from an intentional equipment malfunction [43, 47]. Negative emotions can also be generated by the provoked and unavoidable death of the “patient” [60]. It is important to realise that deception is often purposefully incorporated into scenarios to enhance their authenticity, and hence it is no related to
    non-maleficence but benevolence [43]. If the simulation is multi-professional, and even more so in-situ, then a tension arises between the “good for the team, the unit, the institution” (imagining all possible cases, even the most difficult) and the “good for the learner” (avoiding the feeling of deception). It also raises a dilemma between the scenario's loss of authenticity, which threatens the principle of beneficence, and the learners’ loss of psychological safety, which threatens the principle of non-maleficence [61].

    It is on this basis that a controversy has arisen in the world of SBE about whether or not it is possible to deceive learners for their own good. The key lies in the quality of upstream information, which is the learners’ preparation in the form the pre-briefing and associated learning contract [43].
    The principle of distributive justice applied to the learner is that all learners should benefit from SBE. This requires well trained simulation educators, sufficient training space, and good administrative and technical support and processes. All these elements ensure the reproducibility and accessibility of SBE to all learners.

    For simulated participants
    The ethical aim for a simulated (or standardized) participant or patient (SP) is to increase the realism of a scenario. Learners are still immersed in a controlled environment within which they can make mistakes and develop technical and communication skills without this being harmful to the patient [43].
    The principle of autonomy for the SP corresponds to the freedom to choose to be involved in a scenario depending on the level of physical exposure required, the type of physical assessment or procedures to be performed on them, and the type and tone scenario script language [62]. This is similar to an actor’s right to accept or not a role and its associated script for a movie. Prior information must be as exhaustive as possible, specifying the number of scenarios enacted over a set duration, the break times, and so on. It is also important to provide a framework that includes role portrayal training, image rights, and training to evaluate learners’ performance or providing feedback. Two examples illustrate the possible limits of the role of SPs: Their use to teach pelvic examination [63] or to receive repeatedly a diagnosis with a poor prognosis [64].

    Beneficence. Simulated patients need to work in good conditions, including a space where they can get changed, “get in” and “get out” of character, and wait between scenarios [62, 65].
    The benefits of participating in SBE for SPs can be of various kinds: 1/ Participation in improving the skills of healthcare professionals, particularly for expert patients; 2/ Personal development in another field of theatrical art for actors; 3/ Financial benefits through remuneration for preparation time, simulation-based activity with learners, and travel expenses [65, 66].
    Respecting the principle of non-maleficence corresponds to avoiding the simulated patient's insecurity. This is essentially psychological but also physical insecurity in relation to body parts exposure. This means ensuring the psychological safety and mental wellbeing of the SPs by taking care of not awakening negative prior experiences, evaluating the impact of the frequency of training situations on the SPs’ psyche (e.g., the consequences of being diagnosed with cancer several times a day/week), and debriefing the SPs regularly about their role and experience and offering the support of a psychologist if needed [65, 67].
    Distributive justice would correspond to the national and international availability and use of SPs for the training of healthcare professionals in SBE programmes.
    Other principles:
    There is a professional ethical principle whereby the SPs must accept to take part in training sessions to learn how to act as per the patient they need to impersonate and how to provide feedback to learners or complete evaluation forms about their performance. They need to accept receiving feedback on their own acting performance. They must respect a certain number of points linked to SBE [62]. These include adhering to the principles of simulation including confidentiality (especially for in-situ simulation) and benevolence.

    Special features

    Ethics and disclosure of bad news
    When it comes to breaking bad news in simulation, the psychological safety of learners and SPs cannot be ignored. It is part of professional ethics, without which learning becomes random or dangerous. Indeed, the disclosure of bad news refers to the emotions expressed by SPs that can provoke a psychological distress in relation to an event already experienced by learners [68]. This can raise ethical issues and cause trauma for learners [69]. For this reason, making sure at an earlier stage that this type of simulation does not disturb the learner and that the verbal and behavioural expressions of the SPs are not too destabilizing for a beginner learner helps to ensure their
    psychological safety.

    Such assessment can be based on the SPIKES method (Setting, Perception, Invitation, Knowledge, Empathy, Strategy, and Summary) [70] or its French translations – EPICES (Environnement, Perception, Invitation, Connaissances, Empathie, Stratégie et Synthèse) [71].

    Ethics and death in simulation
    After several decades of simulation during which educators advocated against allowing the simulator to die unless death was part of the learning objectives [72], this practice has been called into question.
    There is a profound discrepancy between cardiopulmonary resuscitation (CPR) management in simulation compared to real life: it is shorter and a lot less sad [73]. The risk is therefore a loss of “fidelity” of the scenario and thus a threat to the principle of beneficence as the learning experience no longer fully exposes learners to the reality of clinical practice.
    It has also been reported that presenting scenarios with a systematic death of the manikin leads to an increase in anxiety-depression with increased State-Trait Anxiety Inventory (STAI) scores [60]. This consequence was not reported in another randomized study [74]. But a recent meta-analysis has shown an association between an increased STAI score and anxiety or depression [75]. A randomized trial reported that students exposed to unexpected simulated patient death had more negative emotions, higher cognitive load, and were less competent to diagnose and manage a case [76]. This risk of negative impact is important to note as an element that could threaten the principle of non-maleficence. There is therefore a dilemma between the principle of beneficence and that of non-maleficence.
    In the context of death during SBE, the principle of autonomy involves fully informing learners about the possibility of death and obtaining learners' consent [42]. In one study learners had the same sense of self-efficacy having been informed or not of the possible manikin's death beforehand [77]. The unexpected death of the manikin in simulation is only conceivable and ethical if learners are informed during the pre-briefing and that they give their consent [43, 78].
    Thus, the possibility of the manikin's death in simulation appears ethical if: 1/ it is appropriate to the scenario; 2/ the learner is experienced and has already seen deteriorating patients; in another words, it should not be with novice learners, given the potentially deleterious effect of the emotional shock of being confronted with death early on in vocational training. [79]; 3/ the principle of autonomy is respected (learners are fully informed beforehand that the manikin may sometimes die) and learners give their consent. Prior to a particularly difficult scenario, it is important to inform learners that it involves 'critical' actions with a strong correlation with whether or not the manikin will survive (Table 2, Type 5).

    Table 2 presents different speculative possibilities in relation to the patient’s death during SBE activities. The first possibility is to mimic clinical reality with less than 10% of survival (and increase learning gains and therefore beneficence), but at the risk of learner dissatisfaction and therefore less non-maleficence. Conversely, the second option provides over 90% survival after simulated cardiac arrest, which increases learner satisfaction, but at the risk of being less realistic.
    The same applies to option 3 with the manikin surviving all the deleterious learners’ actions that could lead to death. On the other hand, the fourth possibility, which links each deleterious action to the manikin's death, although realistic, seems excessive and will greatly diminish learners' sense of satisfaction.
    The fifth possibility of presenting death in simulation seems ethically the least unfavourable. It allows the manikin to sometimes die in very specific cases where the action/inaction of the learners has a strong causal link with the outcome. It is therefore directed by the learners' performance and leads us to consider that a simulation educator may sometimes intentionally deceive learners for their own good (by authorizing the manikin's death if the action with a strong correlation with survival has not been carried out or if inaction is automatically linked to death). This way of representing death in simulation may, in some cases, reduce learner satisfaction and create a degree of frustration, but it also increases learning [43].
    Interestingly, this ethical resolution of the problem of death in simulation upsets Kirkpatrick's pyramid at its base, as far as it is not necessary to have learner satisfaction to improve their knowledge or skills. Further research is needed to fully explore this theme, and in particular, the psychological effects of manikin death.

    Ethics and research
    For the researcher, professional ethics include compliance with the Simulationist Code of Ethics [32, 37], the use of simulation according to one of the 4 modalities described (intervention, evaluation, context, pretext), and full information for the research participant on the same elements as the learner during a simulation session (Pre-briefing and briefing) [80].
    When a participant is included in a simulation-based research study, written consent is mandatory [81]. Often there are inconveniences associated with research evaluation studies such as biological sample testing (e.g. blood, urine, saliva), wearing sensors, completing numerous questionnaires, not smoking for 24 hours, etc [82]. To respect the principle of beneficence for all, researchers must provide an equal training opportunity to the “non-simulation” group (control group) participants after the research has been conducted [83].

    Ethics and the use of biological tissue
    The ethical aim here is not the professional protection of the learner (guaranteed by the educator), but rather the respect and protection of the biological tissue(s) used in the course of a mostly procedural simulation-based activity.
    For the educator, it is in all cases a professional ethics of respect for regulations concerning the use of animals or parts of animals [52, 53], and cadavers donated to science [5, 53] as presented in the first example of the foreword. The ethical guarantor with regards to biological tissues is the anatomy laboratory’s ethics committee acting as a protector of the ethics linked to the management of biological tissues [5]. However, the guarantor of ethics with regards to learners remains the educator, responsible for the application of learning regulations (see “Ethics for the learner” above). This dual ethical protection is specific to procedural simulation and must be precisely organized and validated in every SBE activity of this type.
    As far as the whole animal is concerned, the essential ethical aspect is to provide sufficient analgesia or anaesthesia so as not to cause suffering [52, 53]. The French National Committee for Ethical Reflection on Animal Experimentation is tasked with ethical issues related to animal experimentation [84].
    Concerning the use of cadavers in simulation (complete subjects or anatomical parts), the framework has been precisely defined by a recent French Decree [5], which sets out the principles and procedures (ethics, scientific, and educational committee).
    In addition to the guarantees provided by the various committees of the body donation centres (ethical, scientific, and pedagogical) of the Law [5], one must adhere to the respect due to the deceased human body [85], and provide a prevention of viral infections by searching for any viral infectious agents on bodies donated to science before they are used [86].

    Teaching ethics through simulation
    Learning ethics through simulation plays an important professional role. It contributes to the preservation of values and cultural heritage of societies and healthcare systems, which is a major concern of educational systems [87]. Although not frequently used, simulation enables learners to acquire bioethical principles for the patient [88]. Ethics in medicine and nursing takes place in situations that are inherently uncertain and open-ended [89]. Simulation can be designed to reflect the choices faced by patients and clinicians, and the factors that influence the dynamics between them, and present them in a context that emphasizes the need for a nuanced approach to ethics education and practice [89]. Simulation then provides learners with the opportunity to develop the knowledge and skills needed to manage complex situations and ethical dilemmas [90]. Nevertheless, the complex nature of the scenarios means that they are aimed at end-of-course learners who have already a wide experience of medico-technical situations.
    The teaching of bioethics in simulation has been reported in medical [91], nursing [92] and midwifery studies [90]. It is fundamental to teach about ethics in nursing education as nurses are considered the biggest human capital in the health care system [93]. In addition, simulation has been used to determine, on an assessment scale, the threshold value of skills needed in ethical decision-making [94]. Finally, SBE provides insights into the application of bioethics in other countries and cultures [95].

    Ethics and computer simulation
    According to Moor's Law, there is a correlation between technological advances and social and ethical impacts [96]. VR, and more broadly the sensory virtualization of all or part of the simulation environment, opens up a new dimension of ethical concerns. This development threatens virtue ethics like any new development in human activity [34].
    While the potential benefits of VR are heralded by some as limitless possibilities (Metaverse), there is in fact a necessary debate on its real educational efficiency and on the ethical implications that this technology represents in relation to its physiological, cognitive, and behavioural impacts. There may be visual or even pluri-sensory isolation of the educator/learner pair, as well as isolation regarding social dynamics and inter-individual relations [97]. The beneficence of this approach was the first to be raised as potentially threatened or modified by VR for clinicians and patients [98], as well as lay people [99].
    The second concern has been distributive justice as simulation using VR is not financially accessible to all training programmes, even though it promises to be an important teaching tool [100]. It seems that currently the crucial problem is that of “virtual ownership” of both the educational content and the information gathered and processed through machine learning. This is a threat to the principle of learner autonomy. For example, a user may be considered the owner of an island in a virtual world, but the entire world, including the island, may be the property of the company that created it and allows users to ”live” in it [101]. For example, the development of many surgical training software is in fact financed by industry, such as implant manufacturers, with the aim not only of promoting the implantation technique for the trained professional, but also of commercially seeding their product to inexperienced learners. A whole virtual economy can develop here, as in Second Life [102].

    VR presents a major potential ethical problem, as the technology and financing it imposes can generate a deleterious relationship of dependency between the financial world and the world of healthcare training, particularly through the exploitation of personal physical and psychological data, which may be collected without the knowledge of their authors and for unknown purposes. There is therefore a great vulnerability to this technique, which can be a source of abuse for malicious or financial purposes [103]. The same applies to augmented reality (AR), which can fall victim to misuse and whose data can also be the source of abuse [104]. In order to respect the integrity of human beings and their ability to decide for themselves what is done with their own data, it is essential to lay down precise operating rules for the collection and use of such data [105]. As technology and SBE practices evolve, it is necessary to ensure that ethical principles are always followed, especially as AI may easily ignore related core principles without us realising it. There lay further important ethical questions.

    Conclusion

    Bioethics was mainly developed for healthcare research and has been extended to patient care. We think it is mandatory to spread its principles to SBE activities with respects to all stakeholders, including the learners, educators, simulated participants, and the patients themselves. Healthcare SBE retains its core ethical foundation of beneficence: “Never the first time on the patient”. However, in its many developments and modalities, simulation must respect bioethical principles. This ethical perspective enables SBE to be seen in a different light and to meet requirements other than those hitherto accepted.
    This allows us to explore the ethical dimensions of each stakeholder’s practices in SBE and to see how changes over time can alter ethical tensions, prompting us to exercise greater caution. It also enables the development in each centre, of an SBE network built in accordance with bioethical principles, with the ultimate goal of improving patient care. Research is needed to develop a differentiated perspective based on cultures and practices, in order to better understand the specific characteristics of each.

    Author contributions
    All authors contributed equally and validated the final version of record.
    Declarations
    Conflicts Of Interests
    The Author declares that there is no conflict of interest.
    Funding
    This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
    Registration
    No registration applicable.
    Data availability statement
    The data that support the findings of this study are available from the corresponding author upon reasonable request.
    Ethical approval
    Ethical approval for this study was not required.

    References

    1.            Smith WR, Audi R. Religious Accommodation in Bioethics and the Practice of Medicine. The J Med Philo. 2021;46(2):188–218. https://doi.org/10.1093/jmp/jhaa038

    2.            Gray B. (Bio)Ethics in a Pluralistic Society. Challenges. 2019;10(1):12. https://doi.org/10.3390/challe10010012

    3.            French National Assembly and Senate. Loi 94-654 du 29 juillet 1994 relative au don et à l’utilisation des éléments et produits du corps humain, à l’assistance médicale à la procréation et au diagnostic prénatal [Internet]. Jul 29, 1994. Available from: https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000000549618

    4.            Jouan A. Don de corps à la science : un charnier au coeur de Paris. L’Express [Internet]. 2019 Nov 26; Available from: https://www.lexpress.fr/sciences-sante/sciences/don-de-corps-a-la-science-un-charnier-au-coeur-de-paris_2108389.html?cmp_redirect=true

    5.            Décret n° 2022-719 du 27 avril 2022 relatif au don de corps à des fins d’enseignement médical et de recherche [Internet]. Apr 27, 2022. Available from: https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000045684251

    6.            Moutel G, Gouriot M, Suzat B, Batteur A, Ploteau S, Destrieux C et al. Don du corps à la science. Med Sci (Paris). 2023;39(2):164–9. https://doi.org/10.1051/medsci/2023011

    7.            Schicktanz S, Welsch J, Schweda M, Hein A, Rieger JW, Kirste T. AI-assisted ethics? considerations of AI simulation for the ethical assessment and design of assistive technologies. Front Genet. 2023;14:1039839. https://doi.org/10.3389/fgene.2023.1039839

    8.            Haute Autorité de Santé [Internet]. 2024 [cited 2025 May 22]. Bonnes pratiques en matière de simulation en santé. Available from: https://www.has-sante.fr/jcms/p_3505883/fr/bonnes-pratiques-en-matiere-de-simulation-en-sante

    .9.           Cook DA, Hatala R, Brydges R, Zendejas B, Szostek JH, Wang AT et al. Technology-Enhanced Simulation for Health Professions Education. JAMA. 2011;306(9):978–88. https://doi.org/10.1001/jama.2011.1234

    10.          McGaghie WC, Issenberg SB, Cohen MER, Barsuk JH, Wayne DB. Does simulation-based medical education with deliberate practice yield better results than traditional clinical education? A meta-analytic comparative review of the evidence. Acad Med. 2011;86(6):706–11. https://doi.org/10.1097/acm.0b013e318217e119

    11.          Beauchamp T, Childress J. Principles of Biomedical Ethics: Marking Its Fortieth Anniversary. The Am J Bioeth. 2019;19(11):9–12. https://doi.org/10.1080/15265161.2019.1665402

    12.          Ziv A, Wolpe PR, Small SD, Glick S. Simulation-based medical education: an ethical imperative. Acad Med. 2003;78(8):783–8. https://doi.org/10.1097/00001888-200308000-00006

    13.          Smith A, Lammers S. The ethics of simulation. In: Palaganas JC, Maxworthy JC, Epps CA, Mancini ME, editors. Defining excellence in simulation programs. Philadelphia: Wolters Kluwer; 2014. p. 592–6.

    14.          Budić I, Pavlović S, Stević M, Petrov I, Perić V, Jović M et al. Medical simulation: Moral and ethical issues. Acta Medica Medianae. 2018;57(1):64–9. https://doi.org/10.5633/amm.2018.0110

    15.          Garbayo L, Stahl J. Simulation as an ethical imperative and epistemic responsibility for the implementation of medical guidelines in health care. Med Health Care and Philos. 2017;20(1):37–42. https://doi.org/10.1007/s11019-016-9719-0

    16.          Institute of Medicine (US) Committee on Quality of Health Care in America. To Err is Human: Building a safer health system [Internet]. Kohn LT, Corrigan JM, Donaldson MS, editors. Washington (DC): National Academies Press (US); 2000.

    17.          French National Assembly and Senate. Loi n° 2002-303 du 4 mars 2002 relative aux droits des malades et à la qualité du système de santé [Internet]. Mar 4, 2002. Available from: https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000000227015

    18.          Graber MA, Wyatt C, Kasparek L, Xu Y. Does Simulator Training for Medical Students Change Patient Opinions and Attitudes toward Medical Student Procedures in the Emergency Department? Acad Emerg Med. 2005;12(7):635–9. https://doi.org/10.1197/j.aem.2005.01.009

    19.          Kirkpatrick DL. Evaluation of training. In: Donald L, Craig RL, Bittel LR, editors. Training and Development Handbook. New York: McGraw Hill; 1970. p. 87–112.

    20.          Barsuk JH, McGaghie WC, Cohen ER, O'Leary KJ, Wayne DB. Simulation-based mastery learning reduces complications during central venous catheter insertion in a medical intensive care unit. Crit Care Med. 2009;37(10):2697–701.

    21.          Draycott T, Sibanda T, Owen L, Akande V, Winter C, Reading S et al. Does training in obstetric emergencies improve neonatal outcome? BJOG. 2006;113(2):177–82. https://doi.org/10.1111/j.1471-0528.2006.00800.x

    22.          Cohen ER, Feinglass J, Barsuk JH, Barnard C, O'Donnell A, McGaghie WC et al. Cost savings from reduced catheter-related bloodstream infection after simulation-based education for residents in a medical intensive care unit. Simul Healthc. 2010;5(2):98–102. https://doi.org/10.1097/sih.0b013e3181bc8304

    23.          Cuvelier L. “Never the first time on a patient”: the stakes of high-fidelity simulation for safety training. Development and Learning in Organizations. 2018;32(5):23–5. https://doi.org/10.1108/DLO-09-2018-131

    24.          Hssain I, Alinier G, Souaiby N. In-situ simulation: A different approach to patient safety through immersive training. Mediterranean Journal of Emergency Medicine. 2013;15:17–28.

    25.          Cant RP, Cooper SJ, Lam LL. Hospital nurses' simulation-based education regarding patient safety: A scoping review. Clin Simul Nurs. 2020;44:19–34. https://doi.org/10.1016/j.ecns.2019.11.006

    26.          McLeod J, McLeod S. Simulation in the Service of Society. SIMULATION. 1988;51(3):130–2. https://doi.org/10.1177/003754978805100307

    27.          Alinier G, Platt A. International overview of high-level simulation education initiatives in relation to critical care. Nurs Crit Care. 2014;19(1):42–9. https://doi.org/10.1111/nicc.12030

    28.          Chimbe Phiri E, Chaputula B, Shawa E, Chiaravalli J, Sigalet E, Gabriel J et al. A Simulation Scenario Focused on Resuscitation of a Young Infant (Neonate) for Nurses and Midwives in Malawi, a Limited Resource Country. Cureus. 2018;10(5):e2673. https://doi.org/10.7759/cureus.2673

    29.          Versantvoort JMD, Kleinhout MY, Ockhuijsen HDL, Bloemenkamp K, de Vries WB, van den Hoogen A. Helping Babies Breathe and its effects on intrapartum-related stillbirths and neonatal mortality in low-resource settings: a systematic review. Arch Dis Child. 2020;105(2):127–33. https://doi.org/10.1136/archdischild-2018-316319

    30.          Danion J, Breque C, Oriot D, Faure J, Richer J. SimLife® technology in surgical training–a dynamic simulation model. J Visc Surg. 2020;157(3):S117–S22. https://doi.org/10.1016/j.jviscsurg.2020.02.013

    31.          Haute Autorité de Santé [Internet]. 2012 [cited 2013 January 5] Guide de bonnes pratiques en matière de simulation en santé. Available from: http://www.has-sante.fr/portail/jcms/c_1355008/guide-bonnes-pratiques-simulation-sante-guide

    32.          Society for Simulation in Healthcare. Simulationist Code of Ethics [Internet]. 2019 [cited 2025 May 22]. Available from: https://www.ssih.org/SSH-Resources/Code-of-Ethics

    33.          Oriot D, Alinier G. La simulation en santé - Le débriefing clés en mains [Internet]. Masson; 2019. 192 p.

    34.          Doukas DJ, Ozar DT, Darragh M, de Groot JM, Carter BS, Stout N. Virtue and care ethics & humanism in medical education: a scoping review. BMC Med Educ. 2022;22(1):131. https://doi.org/10.1186/s12909-021-03051-6

    35.          Ören T. Responsibility, ethics and simulation. Transactions of the Society for Computer Simulation International. 2000;17(4):165–70.

    36.          Der Sahakian G, Buléon C, Alinier G. Chapter 14 – Educational Foundations of Instructional Design Applied to Simulation-Based Education. In: Chiniara G, editor. Clinical Simulation (Second Edition) [Internet]. Academic Press; 2019. p. 185–206. https://doi.org/10.1016/B978-0-12-815657-5.00014-0

    37.          Watts PI, Rossler K, Bowler F, Miller C, Charnetski M, Decker S et al. Onward and Upward: Introducing the Healthcare Simulation Standards of Best PracticeTM. Clin Simul Nurs. 2021;58:1–4. https://doi.org/10.1016/j.ecns.2021.08.006

    38.          Somerville SG, Harrison NM, Lewis SA. Twelve tips for the pre-brief to promote psychological safety in simulation-based education. Med Teach. 2023;45(12):1349–56. https://doi.org/10.1080/0142159x.2023.2214305

    39.          McDermott DS, Ludlow J, Horsley E, Meakim C. Healthcare Simulation Standards of Best PracticeTM. Prebriefing: Preparation and Briefing. Clin Simul Nurs. 2021;58:9–13. https://doi.org/10.1016/j.ecns.2021.08.008

    40.          Oriot D, Alinier G. Pocket Book for Simulation Debriefing in Healthcare. Springer; 2018.

    41.          Der Sahakian G, Alinier G, Savoldelli G, Oriot D, Jaffrelot M, Lecomte F. Setting Conditions for Productive Debriefing. Simulation & Gaming. 2015;46(2):197–208. https://doi.org/10.1177/1046878115576105

    42.          Alinier G. Developing High-Fidelity Health Care Simulation Scenarios: A Guide for Educators and Professionals. Simulation & Gaming. 2011;42(1):9–26. https://doi.org/10.1177/1046878109355683.

    43.          Alinier G, Oriot D. Simulation-based education: deceiving learners with good intent. Adv Simul. 2022;7(1):8. https://doi.org/10.1186/s41077-022-00206-3

    44.          Muckler VC. Exploring Suspension of Disbelief During Simulation-Based Learning. Clin Simul Nurs. 2017;13(1):3–9. https://doi.org/10.1016/j.ecns.2016.09.004

    45.          Sharma H, Patil AD, Baviskar A. Fiction contract: Its importance in simulation-based medical education. Int J Basic Clin Pharmacol. 2023;12(5):766–70. https://doi.org/10.18203/2319-2003.ijbcp20232579

    46.          Dieckmann P, Manser T, Wehner T, Rall M. Reality and Fiction Cues in Medical Patient Simulation: An Interview Study with Anesthesiologists. Journal of Cognitive Engineering and Decision Making. 2007;1(2):148–68. https://doi.org/10.1518/155534307X232820

    47.          Stephan JC, Kanbar A, Saleh N, Alinier G. The effect of deception in simulation-based education in healthcare: a systematic review and meta-analysis. Int J Healthc Simul. 2023:1–14. https://doi.org/10.54531/hwxl4351

    48.          French National Assembly and Senate. Loi n° 93-121 du 27 janvier 1993 portant diverses mesures d'ordre social [Internet]. Jan 27, 1993. Available from: https://www.legifrance.gouv.fr/loda/id/JORFTEXT000000711603/

    49.          Direction générale de l’offre de soins; Direction générale de la concurrence de la consommation et de la répression des fraudes. NOTE D’INFORMATION N° DGOS/RH2/2020/157 du 11 septembre 2020 relative à l’application de l’article L. 1453-3 du code de la santé publique aux fins de mise en œuvre du dispositif « encadrement des avantages ». [Internet]. 2020 [cited 2025 Jun 3]. Available from: https://www.economie.gouv.fr/files/files/directions_services/dgccrf/boccrf/2020/20_11/note-d-information-11-septembre-2020.pdf

    50.          Conférence des Doyens des facultés de Médecine. Charte de la faculté de médecine/santé [Internet]. 2023 [cited 2025 Jun 1]. Available from: https://conferencedesdoyensdemedecine.org/ethique-et-deontologie/

    51.          Curry AE, Peek-Asa C, Hamann CJ, Mirman JH. Effectiveness of parent-focused interventions to increase teen driver safety: A critical review. Journal of Adolesc Health. 2015;57(1):S6–S14. https://doi.org/10.1016/j.jadohealth.2015.01.003

    52.          Autissier C. Réglementation éthique de l’expérimentation animale en recherche biomédicale. Médecine/Sciences. 2008;24(4):437–42. https://doi.org/10.1051/medsci/2008244437

    53.          Rubeis G, Steger F. Is Live-Tissue Training Ethically Justified? An Evidence-based Ethical Analysis. Altern Lab Anim. 2018;46(2):65–71. https://doi.org/10.1177/026119291804600206

    54.          SoFraSimS. Évaluation Sommative et Simulation en Santé [Internet]. 2022 [cited 2025 May 22]. Available from: https://www.sofrasims.org/articles/117715-evaluation-sommative

    55.          Alinier G, Shehatta AL, Makker R. Simulation for Clinical Skills in Healthcare Education. In: Nestel D, Reedy G, McKenna L, Gough S, editors. Clinical Education for the Health Professions: Theory and Practice. Singapore: Springer Singapore; 2020. p. 1–21.

    56.          Alinier G. A typology of educationally focused medical simulation tools. Med Teach. 2007;29(8):e243–50. https://doi.org/10.1080/01421590701551185

    57.          Kardong-Edgren SS, Farra SL, Alinier G, Young HM. A call to unify definitions of virtual reality. Clin Simul Nurs. 2019;31:28–34. https://doi.org/10.1016/J.ECNS.2019.02.006

    58.          Sinthuraj V, Makker R, Alinier G. Exploring the benefits, challenges, and psychological safety of using cadaveric simulation in medical education and training. Journal of Emergency Medicine, Trauma, and Acute Care. 2025(2025). https://doi.org/10.5339/jemtac.2025.24

    59.          Alinier G, Heinrichs W. Chapter 56 – Train-the-Trainers: Creating Simulation Educators. In: Chiniara G, editor. Clinical Simulation (Second Edition) [Internet]. Academic Press; 2019. p. 857–64.

    60.          Goldberg A, Samuelson S, Khelemsky Y, Katz D, Weinberg A, Levine A et al. Exposure to Simulated Mortality Affects Resident Performance During Assessment Scenarios. Simul Healthc. 2017;12(5):282–8. https://doi.org/10.1097/sih.0000000000000257

    61.          Calhoun AW, Pian-Smith M, Shah A, Levine A, Gaba D, DeMaria S et al. Guidelines for the Responsible Use of Deception in Simulation: Ethical and Educational Considerations. Simul Healthc. 2020;15(4):282–8. https://doi.org/10.1097/sih.0000000000000440

    62.          Lewis KL, Bohnert CA, Gammon WL, Hölzer H, Lyman L, Smith C et al. The Association of Standardized Patient Educators (ASPE) Standards of Best Practice (SOBP). Adv Simul (Lond). 2017;2(1):10. https://doi.org/10.1186/s41077-017-0043-4

    63.          Hendrickx K, Benedicte DW, Wiebren T, Dirk A, Griet P, Wyndaele J-J. Learning intimate examinations with simulated patients: The evaluation of medical students’ performance. Med Teach. 2009;31(4):e139–e47. https://doi.org/10.1080/01421590802516715

    64.          Maguire P, Faulkner A, Booth K, Elliott C, Hillier V. Helping cancer patients disclose their concerns. Eur J Cancer. 1996;32(1):78–81. https://doi.org/10.1016/0959-8049(95)00527-7

    65.          Haute Autorité de Santé [Internet]. 2019 [cited 2025 May 22]. Simulation en santé et gestion des risques: Guide méthodologique. Available from: https://www.has-sante.fr/upload/docs/application/pdf/2019-02/guide_methodologique_simulation_en_sante_et_gestion_des_risques.pdf

    66.          Alinier N, Alinier G. Standardization and professionalization of simulated and standardized patient-based education in Qatar: A call for action. Qatar Med J. 2025;2025(2). https://doi.org/10.5339/qmj.2025.33

    67.          Al Badawi A. Ethical and Educational Perspectives on Involving Children and Adolescents as Simulated Patients in Pediatric Emergency Training. Panorama of Emergency Medicine. 2026;(under review).

    68.          Haute Autorité de Santé [Internet]. 2008 [cited 2025 May 22]. Annoncer une mauvaise nouvelle. Available from: https://www.has-sante.fr/upload/docs/application/pdf/2008-10/mauvaisenouvelle_vf.pdf

    69.          Matos FM, Raemer DB. Mixed-Realism Simulation of Adverse Event Disclosure: An Educational Methodology and Assessment Instrument. Simul Healthc. 2013;8(2):84–90. https://doi.org/10.1097/sih.0b013e31827cbb27

    70.          Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES—A Six-Step Protocol for Delivering Bad News: Application to the Patient with Cancer. Oncologist. 2000;5(4):302–11. https://doi.org/10.1634/theoncologist.5-4-302

    71.          Lüthi FT, Cantin B. Annonce de mauvaises nouvelles: une pointe d'EPICES dans l'apprentissage. Rev Med Suisse. 2011;7:85–7. https://doi.org/10.53738/REVMED.2011.7.277.0085

    72.          Corvetto MA, Taekman JM. To Die or Not To Die? A Review of Simulated Death. Simul Healthc. 2013;8(1):8–12. https://doi.org/10.1097/sih.0b013e3182689aff

    73.          Portanova J, Irvine K, Yi JY, Enguidanos S. It isn’t like this on TV: Revisiting CPR survival rates depicted on popular TV shows. Resuscitation. 2015;96:148–50. https://doi.org/10.1016/j.resuscitation.2015.08.002

    74.          Philippon AL, Bokobza J, Bloom B, Hurbault A, Duguet A, Riou B et al. Effect of simulated patient death on emergency worker’s anxiety: a cluster randomized trial. Ann Intensive Care. 2016;6(1):60. https://doi.org/10.1186/s13613-016-0163-3

    75.          Knowles KA, Olatunji BO. Specificity of trait anxiety in anxiety and depression: Meta-analysis of the State-Trait Anxiety Inventory. Clin Psychol Rev. 2020;82:101928.  https://doi.org/10.1016/j.cpr.2020.101928

    76.          Fraser K, Huffman J, Ma I, Sobczak M, McIlwrick J, Wright B et al. The Emotional and Cognitive Impact of Unexpected Simulated Patient Death: A Randomized Controlled Trial. Chest. 2014;145(5):958–63. https://doi.org/10.1378/chest.13-0987

    77.          Weiss A, Jaffrelot M, Bartier J-C, Pottecher T, Borraccia I, Mahoudeau G et al. Does the unexpected death of the manikin in a simulation maintain the participants’ perceived self-efficacy? An observational prospective study with medical students. BMC Med Educ. 2017;17(1):109. https://doi.org/10.1186/s12909-017-0944-x

    78.          McIlwaine L, Scarlett V, Venters A, Ker JS. The different levels of learning about dying and death: an evaluation of a personal, professional and interprofessional learning journey. Med Teach. 2007;29(6):e151–e9. https://doi.org/10.1080/01421590701294331

    79.          Nickerson M, Pollard M. Simulation Philosophy and Practice: Simulator Patient Death Versus Survival. Clin Simul Nurs. 2009;5(3):e147. https://doi.org/10.1016/J.ECNS.2009.04.063

    80.          Cheng A, Kessler D, Mackinnon R, Chang TP, Nadkarni VM, Hunt EA et al. Reporting guidelines for health care simulation research: extensions to the CONSORT and STROBE statements. Adv Simul (Lond). 2016;1(1):25. https://doi.org/10.1097/sih.0000000000000150

    81.          Rhodes KV, Miller FG. Simulated Patient Studies: An Ethical Analysis. Milbank Q. 2012;90(4):706–24. https://doi.org/10.1111/j.1468-0009.2012.00680.x

    82.          Ghazali DA, Ragot S, Breque C, Guechi Y, Boureau-Voultoury A, Petitpas F et al. Randomized controlled trial of multidisciplinary team stress and performance in immersive simulation for management of infant in shock: study protocol. Scand J Trauma Resusc Emerg Med. 2016;24:36. https://doi.org/10.1186/s13049-016-0229-0

    83.          Alinier G, Hunt B, Gordon R, Harwood C. Effectiveness of intermediate-fidelity simulation training technology in undergraduate nursing education. J Adv Nurs. 2006;54(3):359–69. https://doi.org/10.1111/j.1365-2648.2006.03810.x

    84.          Ministère de l’éducation nationale, de l’enseignement supérieur et de la recherche. Arrêté du 7 juillet 2006 portant nomination au Comité national de réflexion éthique sur l’expérimentation animale. Journal Officiel, 167 (2006).

    85.          Touzeil-Divina M, Bouteille-Brigant M. Le droit du défunt. Communications. 2015;97(2):29–43. https://doi.org/10.3917/commu.097.0029

    86.          Delpech PO, Danion J, Oriot D, Richer JP, Breque C, Faure JP. SimLife a new model of simulation using a pulsated revascularized and reventilated cadaver for surgical education. J Visc Surg. 2017;154(1):15–20. https://doi.org/10.1016/j.jviscsurg.2016.06.006

    87.          Pinar G, Abay H, Akalin A. The effect of senario-based simulation training technology on knowledge and skills of maternity nursing students in Turkey. Int J Dev Res. 2016;6(6):8096–101.

    88.          Smith KV, Witt J, Klaassen J, Zimmerman C, Cheng A-L. High-fidelity simulation and legal/ethical concepts:A transformational learning experience. Nurs Ethics. 2012;19(3):390–8. https://doi.org/10.1177/0969733011423559

    89.          Wilt KE. Simulation-based learning in healthcare ethics education [Doctoral Thesis]. Duquesne University; 2012.

    90.          Buxton M, Phillippi JC, Collins MR. Simulation: A New Approach to Teaching Ethics. J Midwifery Womens Health. 2015;60(1):70–4. https://doi.org/10.1111/jmwh.12185

    91.          Lewis G, McCullough M, Maxwell AP, Gormley GJ. Ethical reasoning through simulation: a phenomenological analysis of student experience. Adv Simul (Lond). 2016;1(1):26. https://doi.org/10.1186/s41077-016-0027-9

    92.          Honkavuo L. Ethics simulation in nursing education: Nursing students' experiences. Nurs Ethics. 2021;28(7–8):1269–81. https://doi.org/10.1177/0969733021994188

    93.          Cheraghi R, Valizadeh L, Zamanzadeh V, Hassankhani H, Jafarzadeh A. Clarification of ethical principle of the beneficence in nursing care: an integrative review. BMC Nurs. 2023;22(1):89. https://doi.org/10.1186/s12912-023-01246-4

    94.          Wasson K, Adams WH, Berkowitz K, Danis M, Derse AR, Kuczewski MG et al. What Is the Minimal Competency for a Clinical Ethics Consult Simulation? Setting a Standard for Use of the Assessing Clinical Ethics Skills (ACES) Tool. AJOB Empir Bioeth. 2019;10(3):164–72. https://doi.org/10.1080/23294515.2019.1634653

    95.          Asao S, Lewis B, Harrison JD, Glass M, Brock TP, Dandu M et al. Ethics Simulation in Global Health Training (ESIGHT). MedEdPORTAL. 2017;13:10590. https://doi.org/10.15766/mep_2374-8265.10590

    96.          Moor JH. Why We Need Better Ethics for Emerging Technologies. Ethics Inf Technol. 2005;7(3):111–9. https://doi.org/10.1007/s10676-006-0008-0

    97.          Kenwright B. Virtual Reality: Ethical Challenges and Dangers [Opinion]. IEEE Technol Soc Mag. 2018;37(4):20–5. https://doi.org/10.1109/MTS.2018.2876104

    98.          Whalley L. Ethical issues in the application of virtual reality to medicine. Comput Biology Med. 1995;25(2):107–14. https://doi.org/10.1016/0010-4825(95)00008-r

    99.          Ramirez E, Tan J, Elliott M, Gandhi M, Petronio L, editors. An Ethical Code for Commercial VR/AR Applications. In: Intelligent Technologies for Interactive Entertainment. Cham: Springer International Publishing; 2021. p. 15–24. https://doi.org/10.1007/978-3-030-76426-5_2.

    100.       Iserson KV. Ethics of Virtual Reality in Medical Education and Licensure. Cambridge Quarterly of Healthcare Ethics. 2018;27(2):326–32. https://doi.org/10.1017/s0963180117000652

    101.       Brey P. Virtual reality and computer simulation. In: Himma KE, Tavani HT, editors. The handbook of information and computer ethics. New Jersey: Wiley; 2008. p. 361–84.

    102.       Hulsen T. Applications of the metaverse in medicine and healthcare. Adv Lab Med. 2024;5(2):159–65. https://doi.org/10.1515/almed-2023-0124

    103.       Spiegel JS. The Ethics of Virtual Reality Technology: Social Hazards and Public Policy Recommendations. Sci Eng Ethics. 2018;24(5):1537–50. https://doi.org/10.1007/s11948-017-9979-y

    104.       Slater M, Gonzalez-Liencres C, Haggard P, Vinkers C, Gregory-Clarke R, Jelley S et al. The Ethics of Realism in Virtual and Augmented Reality. Front Virtual Real. 2020;1:1. https://doi.org/10.3389/frvir.2020.00001

    105.       Evans J. The IEEE Global Initiative on Ethics of Extended Reality (XR) Report: Extended Reality (XR) Ethics in Medicine [Internet]. The Institute of Electrical and Electronics Engineers, Inc.; 2022 Feb. Available from: https://standards.ieee.org/wp-content/uploads/2022/02/whitepaper-ethics-in-medicine.pdf

     

  • A Near-Fatal Anaphylactic Reaction to Biliary Contrast: A Cautionary Case During Laparoscopic Cholecystectomy

    Anaphylactic reactions to iodinated contrast agents during intraoperative cholangiography (IOC) are extremely rare, although such reactions are well documented with intravenous (IV) administration. We present the case of a 71-year-old female with a known allergy to iodinated contrast, who experienced a life threatening anaphylactic reaction immediately after intraoperative cholangiography (IOC) during laparoscopic cholecystectomy. Shortly after the administration of iodinated contrast into the biliary duct, the patient developed supraventricular tachycardia and profound
    hypotension. This case underscores the risk of systemic absorption and hypersensitivity reactions from biliary-administered contrast agents, even in the absence of intravenous exposure. It highlights the need for a comprehensive preoperative allergy evaluation in high-risk patients undergoing biliary procedures and the importance of considering alternative imaging methods to avoid serious complications.

    Introduction

    Cholecystitis, inflammation of the gallbladder mostly due to obstruction of the cystic duct by a gallstone, is considered one of the most frequent indications for laparoscopic cholecystectomy [1]. Intraoperative cholangiography (IOC) is performed during cholecystectomy to visualize the biliary anatomy and identify any residual obstruction [2]. The technique involves inserting a catheter into the cystic duct and injecting an iodinated contrast agent to highlight the biliary tree under fluoroscopy. While this contrast agent is generally safe and plays a crucial role in optimizing surgical outcomes, its use carries a very low risk of hypersensitivity reactions [3]. Although contrast is administered directly into the biliary tree rather than intravenously, iodinated agents can still be absorbed into the systemic circulation, potentially triggering hypersensitivity reactions, including anaphylaxis [4]. While such events are rare during intraoperative cholangiography (IOC), they are clinically significant due to their rapid onset and the potential for general anesthesia to obscure early warning signs like respiratory distress [5]. In this report, we present a critical case involving a 71-year-old female who experienced intraoperative anaphylactic shock following the administration of iodinated contrast dye during IOC in the course of a laparoscopic cholecystectomy for acute cholecystitis. This case highlights the importance of heightened awareness and preparedness for anaphylaxis during interventional oncology procedures.

    Case Presentation

    A 71-year-old woman with a medical history of coronary artery disease (status post placement of two coronary stents), hypothyroidism, diabetes mellitus, and hepatocellular carcinoma (was on tyrosine kinase inhibitor-lenvatinib) presented for one week history of epigastric and right upper quadrant pain, along with postprandial nausea and vomiting. The patient also reported being allergic to intravenous iodinated contrast, characterized by a self-resolving mild skin rash after previous exposure. Abdominal ultrasound (Figure 1) revealed acute cholecystitis, and the patient was planned for cholecystectomy. Preoperative transthoracic echocardiography (TTE) (Figure 2) showed a good left ventricular ejection fraction (60%-65%) with mild septal hypokinesia.

    The patient underwent a laparoscopic cholecystectomy under general anesthesia. During the procedure, the surgeons began by dissecting Calot’s triangle, followed by the introduction of iodinated contrast for intraoperative cholangiography (IOC) (Figure 3) to assess for any residual stones in the bile duct.

    Within minutes, the patient developed tachycardia at a rate of 188 bpm, hypotension with a nadir of 80/56 mm Hg, mydriasis, and absence of brainstem reflexes. The ECG (Figure 4) revealed supraventricular tachycardia (SVT).

    The operating room team promptly performed synchronized cardioversion to restore sinus rhythm and administered 300 mg of intravenous Amiodarone. Following this intervention, the SVT converted to atrial fibrillation, as shown in ECG 2. The differential diagnoses considered included anaphylactic shock, septic shock, acute coronary syndrome, cerebrovascular accident, and pulmonary embolism. A postoperative TTE (Figure 5) showed a normal ejection fraction with no signs of myocardial ischemia. Additionally, echocardiography revealed no evidence of right ventricular strain, effectively ruling out pulmonary embolism. Moreover, CT brain was normal (Figure 6) and Echo Doppler venous lower limbs ruled out deep venous thrombosis. Further investigations, including a non-contrast abdominal computed tomography, excluded other potential causes such as biliary tract perforation and postoperative bleeding. Considering the timing of IOC administration and the lack of alternative explanations, an anaphylactic reaction to the biliary iodinated contrast was deemed the most likely diagnosis, complicated by disseminated intravascular coagulation (DIC) at day 3 post-op.

    The patient was transferred to the intensive care unit (ICU) for close monitoring. Upon admission, the patient received 0.3 mg of Adrenaline intramuscularly and 100 mg of Hydrocortisone intravenously, followed by 50 mg IV of Hydrocortisone every 6 hours. Intravenous antibiotics were initiated, including Amikacin 1 g, Vancomycin 2 g, and continued Meropenem at 1 g IV every 8 hours. Norepinephrine was also infused to maintain MAP > 65 mm Hg. On the third postoperative day, Magnetic resonance cholangiopancreatography (MRCP) (Figure 7) was performed to investigate the persistently elevated cholestatic liver enzymes; however, the results were normal. Over the following days, the patient's clinical condition improved significantly. She was successfully extubated and weaned off vasopressors. Esophagogastroduodenoscopy was performed on day 6 post-op for persistent nausea, revealing candidal esophagitis and multiple gastric polyps. The patient was treated with antifungal agents and subsequently tolerated enteral feeding. The pathology of the resected gallbladder confirmed chronic cholecystitis with multiple yellow stones and wall thickening.

    Discussion

    This case represents only the third reported instance in the literature of anaphylactic shock following the administration of iodinated contrast into the biliary tree during intraoperative cholangiography (IOC), highlighting its rarity and potential lethality [4, 6]. While anaphylaxis is a recognized risk associated with intravenous iodinated contrast, its occurrence via non-vascular routes, such as the biliary system, is exceptionally rare. However, systemic absorption of contrast through the biliary tree can occur, particularly in the presence of inflammation, which may enhance vascular permeability and facilitate entry into the systemic circulation [7].
    To date, only two prior cases have documented similar reactions. Moskovitz et al. described a case of anaphylactic shock following IOC during laparoscopic cholecystectomy in a patient with no prior intravenous contrast exposure, suggesting that biliary administration alone can trigger severe hypersensitivity reactions [4]. Although only available as an abstract, the report highlights the rapid onset of symptoms, including hypotension and respiratory distress, consistent with our patient's presentation [4]. Similarly, Ishiyama et al. reported an intraoperative allergic reaction to biliary contrast that progressed to disseminated intravascular coagulation (DIC), emphasizing the potential for severe systemic complications [6]. The abstract details a case where the reaction led to significant coagulopathy, mirroring the DIC observed in our patient on postoperative day 3 [6]. These cases, despite being limited to abstracts, underscore the clinical relevance and severity of anaphylactic reactions to biliary contrast, particularly in sensitized individuals.
    The pathophysiology of anaphylactoid reactions to iodinated contrast media (ICM) involves non-IgE-mediated mechanisms, primarily through direct activation of mast cells and release of mediators such as histamine, prostaglandins, and bradykinins [8]. Inflammation in the biliary tree, as seen in acute or chronic cholecystitis, may exacerbate systemic absorption, increasing the risk of such reactions [7]. Recent studies suggest that some immediate reactions may involve IgE-mediated pathways, supported by elevated histamine and tryptase levels in affected patients [8]. In our case, the patient’s history of a mild iodinated contrast allergy, combined with rapid cardiovascular collapse and laboratory evidence of DIC (e.g., elevated D-dimer, decreased platelets, and prolonged INR on day 3), strongly supports an anaphylactoid reaction complicated by coagulopathy.
    The occurrence of DIC in this context is exceptionally rare. A review by Andreucci M et al. notes that iodinated contrast can trigger DIC through endothelial injury and activation of the coagulation cascade, particularly in patients with underlying inflammatory conditions [9]. The elevated D-dimer (8068 on day 2, 3755 on day 3) and decreased fibrinogen (177 mg/dl on day 3) in our patient align with this mechanism, suggesting that the anaphylactoid reaction may have initiated a systemic inflammatory response leading to DIC. The absence of other causes, such as sepsis or massive hemorrhage, further supports this association.
    Management of anaphylactoid reactions requires immediate intervention. Epinephrine, administered intramuscularly, remains the cornerstone of treatment for systemic symptoms like hypotension and bronchospasm [5]. Our patient received 0.3 mg of adrenaline and hydrocortisone, with norepinephrine to support blood pressure, consistent with guideline-directed therapy. The subsequent development of DIC necessitated close monitoring and supportive care, including blood products if bleeding had occurred, though this was not required in our case.
    To prevent such reactions, preoperative strategies are critical. Patients with a history of contrast allergy, even if mild, should be evaluated thoroughly. Premedication with corticosteroids and antihistamines is commonly used, but its efficacy is debated, as it does not eliminate the risk of severe reactions [5]. Alternative imaging modalities, such as intraoperative ultrasound, indocyanine green (ICG) fluorescence cholangiography, or preoperative magnetic resonance cholangiopancreatography (MRCP), offer safer options for visualizing the biliary tree [10]. ICG fluorescence, in particular, has gained attention for its safety profile and effectiveness in delineating biliary anatomy without the risks associated with iodinated contrast [10]. Gadolinium-based agents, while used in some cases, carry their own risks and are not universally recommended for biliary imaging [11].
    This case also highlights the need for surgical teams to maintain vigilance for rare complications like DIC. Monitoring for coagulopathy, including serial measurements of INR, fibrinogen, and D-dimer, is essential in patients with suspected anaphylactoid reactions to contrast. Future research should focus on identifying risk factors for such reactions and optimizing alternative imaging techniques to enhance patient safety during laparoscopic cholecystectomy.

    Conclusion

    Anaphylactic shock resulting from intra-biliary contrast administration is a rare but potentially fatal complication during IOC, particularly in patients with a known allergy to iodinated contrast, even those with only mild previous reactions. This case highlights the importance of thorough preoperative allergy evaluations, especially for high-risk individuals. It also underscores the need to consider alternative imaging techniques such as MRCP, intraoperative ultrasound, indocyanine green fluorescence cholangiography, or gadolinium-based agents to mitigate risk. Given the critical role of IOC in laparoscopic cholecystectomy, further research is warranted to develop strategies that minimize contrast-related risks and identify safer imaging options for vulnerable patients. Conversely, our case underscores another exceptionally rare adverse event linked to IOC: disseminated intravascular coagulation (DIC). While DIC is a recognized complication of iodinated contrast media, its occurrence following biliary administration is extremely rare and not well-documented in the literature. Clinicians should remain vigilant for signs of coagulopathy following contrast administration.

    Author contributions
    All authors contributed equally and validated the final version of record.
    Declarations
    Conflicts Of Interests
    The Author declares that there is no conflict of interest.
    Funding
    This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
    Registration
    No registration applicable.
    Data availability statement
    The data that support the findings of this study are available from the corresponding author upon reasonable request.
    Ethical approval
    Ethical approval for this study was not required.
    Patient consent
    Authors confirmed that they have received patient consent to publish this case.

    References
    1. Strasberg SM. Acute calculous cholecystitis. N Engl J Med. 2008;358(26):2804–2811. https://doi.org/10.1056/NEJMcp0800929
    2. Flum DR, Cheadle A, Prela C, Dellinger EP, Chan L. Bile duct injury during cholecystectomy and survival in medicare beneficiaries. JAMA. 2003;290(16):2168–2173. https://doi.org/10.1001/jama.290.16.2168
    3. Bettmann MA. Frequently asked questions: iodinated contrast agents. Radiographics. 2004;24 suppl 1:S3–S10. https://doi.org/10.1148/rg.24si045519
    4. Moskovitz AH, Bush WH, Horvath KD. Anaphylactoid reaction to intraoperative cholangiogram. Report of a case, review of literature, and guidelines for prevention. Surg Endosc 2001;15(10):1227. https://doi.org/10.1007/s004640041033
    5. Brockow K, Christiansen C, Kanny G, Clément O, Barbaud A, Bircher A et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy. 2005;60(2):150–158. https://doi.org/10.1111/j.1398-9995.2005.00745.x
    6. Ishiyama T, Murakami N, Takeda T, Shimonaka H, Dohi S. [Anaphylactoid reactions to contrast media which occurred during cholecystectomy and subsequent disseminated intravascular coagulation–a case report]. Masui. 1992;41 8:1314–8.
    7. Muñoz-Cano R, Pascal M, Araujo G, Goikoetxea MJ, Valero AL, Picado C et al. Mechanisms, Cofactors, and Augmenting Factors Involved in Anaphylaxis. Front Immunol. 2017;8:1193. https://doi.org/10.3389/fimmu.2017.01193
    8. Bottinor W, Polkampally P, Jovin I. Adverse reactions to iodinated contrast media. Int J Angiol. 2013;22(3):149–154. https://doi.org/10.1055/s-0033-1348885
    9. Andreucci M, Solomon R, Tasanarong A. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int. 2014;2014:741018. https://doi.org/10.1155/2014/741018
    10. Boni L, David G, Mangano A, et al. Clinical applications of indocyanine green (ICG) enhanced fluorescence in laparoscopic surgery. Surg Endosc. 2015;29(7):2046–2055. https://doi.org/10.1007/s00464-014-3895-x
    11. Ose K, Doue T, Zen K, Hadase M, Sawada T, Azuma A et al. 'Gadolinium' as an alternative to iodinated contrast media for X-ray angiography in patients with severe allergy. Circ J. 2005;69(4):507–509. https://doi.org/10.1253/circj.69.507

  • Beyond the Checklist: A Scaffolded, Experiential Learning Framework for Medical Rescue Simulation (Part 1 of 2)

    The effective training of Technical Rescue Specialists (TRS) for high-stakes dynamic environments requires a sophisticated pedagogical approach. This article introduces a comprehensive framework for Simulation-based Education (SBE) designed to elevate Medical Rescue Simulation (MRS). The framework is built upon four interconnected pillars: Foundational Learning Theory, Systematic Skill Scaffolding, Integrated Physical Preparedness, and Stringent Safety Protocols. This article will concentrate specifically on Kolb's learning cycles and the principles of scaffolding. Grounded in Kolb's Experiential Learning Cycle, the framework ensures that learning moves beyond rote memorisation to foster deep understanding and adaptive expertise. The core pedagogical strategy involves scaffolding complex medical rescue procedures, by deconstructing them into isolated, manageable skills. Students’ progress through scenarios of increasing fidelity and complexity, from low-fidelity drills and Visually Enhanced Mental Rescue Simulations (VEMRS) to immersive, high-fidelity exercises, that mirror real-world pressures. This structured progression manages cognitive load, and is designed to cultivate the "emergence" of proficient practice by ensuring foundational competencies are robustly established, thereby preventing the "absence" of critical skills in high-stakes situations.

    Introduction

    The effective training of Technical Rescue Specialists (TRS) within higher education institutions, particularly in the demanding and high-stakes context of medical rescue operations, requires a pedagogically sound and integrated approach. These environments are characterised by dynamic, unpredictable scenarios that demand not only technical proficiency but also rapid decision-making, physical endurance, and cohesive teamwork [1]. In response to these challenges, Simulation-based Education (SBE) has emerged as a cornerstone methodology, offering a controlled yet realistic platform for the development of critical competencies, reflective practice, and performance assessment [2]. Central to the success of SBE in medical rescue training is a framework built upon four interconnected pedagogical pillars: Foundational Learning Theory, Systematic Skill Scaffolding, Integrated Physical Preparedness, and Stringent Safety Protocols.

    These pillars collectively support the development of resilient, competent TRS capable of navigating the complexities of real-world emergencies. However, this article focuses specifically on the first two pillars, foundational learning theory and systematic skill scaffolding, as the primary mechanisms for effective learning within Medical Rescue Simulation (MRS). While the importance of physical conditioning and safety protocols is acknowledged, their detailed exploration falls outside the scope of this article.

    The theoretical foundation of this framework draws on Kolb’s Experiential Learning Cycle (ELC), which conceptualises learning as a cyclical process involving concrete experience, reflective observation, abstract conceptualisation, and active experimentation [3,4]. This model ensures that learners engage deeply with simulation scenarios, moving beyond passive participation to develop adaptive expertise through structured reflection and iterative practice. Complementing this, is the principle of scaffolding, informed by Vygotsky’s Zone of Proximal Development (ZPD), which provides a systematic approach to managing cognitive load. By deconstructing complex procedures into isolated skills and gradually increasing scenario fidelity and complexity, scaffolding enables learners to acquire competence incrementally, and with appropriate support [12,15].

    This article aims to articulate a theoretically grounded and practically applicable framework for SBE in MRS. By focusing on the foundational mechanisms that underpin effective learning, it offers educators and programme developers a structured guide to optimise simulation design and delivery. Ultimately, this approach seeks to foster the emergence of competent practice while mitigating the risk of absence in critical skills, ensuring that TRS are not only prepared to perform effectively but also to adapt and thrive in the unpredictable realities of emergency medical operations.

    Guiding Educational Philosophies for Medical Rescue Simulation (MRS)

    The effective training of TRS, particularly within the demanding context of South Africa, necessitates a robust pedagogical foundation. Medical rescue operations are characterised by high stakes, dynamic environments, and the critical need for skilled individuals to work within teams [1]. Simulation-based training has emerged as a cornerstone for developing the requisite competencies, offering a safe and controlled environment for practice and assessment [2].

    Central to effective MRS is the principle of experiential learning, best exemplified by David Kolb's ELC [3]. This model posits that learning is a cyclical process involving four distinct stages: Concrete Experience (CE), Reflective Observation (RO), Abstract Conceptualisation (AC), and Active Experimentation (AE). This cycle provides a comprehensive framework for designing MRS sequences, that move beyond rote memorisation to foster deep understanding, critical reflection, and adaptive expertise [4].

    The integration of Kolb's ELC into a structured MRS curriculum is illustrated below (Figure 2).

    ●     AC - Theory Lectures: The learning journey commences with the introduction of foundational knowledge. During theory lectures, students are exposed to the core concepts, principles, operational protocols, and theoretical underpinnings essential for medical rescue operations. This stage is vital as it establishes the cognitive architecture upon which practical skills and experiential understanding will be built. Without this initial framework, subsequent hands-on activities may lack the necessary context and depth, hindering the development of true comprehension. This aligns with the broader imperative for evidence-based practice in medical rescue, where actions are informed by established knowledge [5].

    ●     CE & AC - Equipment Orientation: This phase serves as a crucial bridge between theoretical knowledge and its tangible application. Students engage in an initial Concrete Experience by physically handling and familiarising themselves with medical rescue equipment. Simultaneously, this interaction reinforces Abstract Conceptualisation, by allowing students to connect the theoretical functions and principles of the equipment (learned in lectures) to its actual features, operation, and limitations. This transitional stage is significant because it embodies the understanding that knowledge must not only be intellectually grasped but also practically engaged with to become meaningful [6].

    ●     CE & RO - Isolated Skills Practice and Sign-off: This stage places a strong emphasis on Concrete Experience through the active practice of specific, discrete medical rescue skills. Students repeatedly perform these skills in a controlled setting. The "sign-off" component, which involves assessment and feedback from instructors, directly facilitates Reflective Observation. Students are prompted to reflect on their performance of each skill, identify areas requiring improvement, and consider the effectiveness of their techniques. This reflection can lead to a refined understanding (AC) of how to execute the skill proficiently. This stage underscores the value of deliberate practice and the indispensable role of structured reflection and feedback in skill acquisition and refinement, linking directly to professional accountability and standards of competence [6].

    ●     CE - Team MRS Practice: Following the mastery of isolated skills, students progress to a more complex and richer experience. Here, they must apply their theoretical knowledge, equipment handling abilities, and individual procedural skills, within a dynamic, interactive, and often immersive team environment. These MRS are designed to mirror the complexities and pressures of real-world medical rescue scenarios. This stage represents the core of experiential learning for professions that rely heavily on teamwork. It shifts the focus from individual skill execution to integrated team performance, fostering an understanding of team dynamics, communication, and coordinated action elements, crucial for successful medical rescue outcomes [7].

    The immersive nature of these MRS promotes situated cognition, where learning is deeply embedded in the context of practice [8].

    ●     RO & AC - Team Assessment: This critical stage is heavily weighted towards Reflective Observation and the subsequent development of new Abstract Conceptualisations. Through comprehensive debriefing sessions, performance reviews, and multi-source feedback (including self-assessment, peer feedback, and instructor evaluations), students and teams meticulously analyse what occurred during the MRS. They explore the rationale behind actions taken, the consequences of those actions, and how their collective performance aligned with established principles, protocols, and objectives. This structured reflection is not merely a feedback mechanism; it is a profound learning process that facilitates the deconstruction of the experience, an understanding of cause-and-effect relationships, and the re-conceptualisation of their mental models and approaches [9]. This leads to new insights, modified strategies, and a deeper, more nuanced understanding (AC) of medical rescue operations.

    ●     AE - Application and Iteration: The cycle culminates in Active Experimentation. Based on the rich RO and refined AC generated during the team assessment and debriefing, students plan how to apply their revised understandings and newly acquired insights in future contexts. This could involve subsequent, more challenging MRS, further targeted practice, or, ultimately, application in real-world medical rescue situations, which becomes a new Concrete Experience, restarting the cycle, ideally at a progressively higher level of competence. This stage emphasises that learning is not a terminal event but a continuous, recurring process of action, reflection, and adaptation. This iterative nature is fundamental for professions like medical rescue that demand lifelong learning, continuous quality improvement, and the constant pursuit of enhanced performance [10].

    The consistent application of Kolb's ELC in MRS naturally fosters a pedagogical shift from a predominantly didactic, teacher-centred approach, to a more facilitative, student-centred philosophy. The emphasis on students actively engaging in experiences (CE) and critically reflecting on those experiences (RO) empowers them to construct their own understanding and meaning.

    Scaffolding the Complex Medical Rescue Procedures Through MRS

    The development of proficient and adaptable TRS necessitates pedagogical approaches, that can effectively bridge the gap between theoretical knowledge and the complex, often chaotic, realities of emergency situations [11]. SBE has emerged as a cornerstone in this endeavour, providing a safe yet realistic environment for students to practice and refine critical skills. Within SBE, the principle of scaffolding offers a robust framework for structuring learning experiences, enabling the incremental acquisition of complex medical rescue competencies [15].

    The Principle of Scaffolding in SBE

    Scaffolding, in an educational context, refers to a process whereby students are provided with temporary, tailored support to achieve learning outcomes that would otherwise be beyond their unassisted reach. This support is gradually withdrawn as the student's proficiency and independence increase [15]. The concept, most famously associated with Vygotsky's (1978) notion of the Zone of Proximal Development (ZPD), posits that learning is most effective when it occurs in the space between what a student can do independently and what they can achieve with guidance [12, 13].

    In SBE for complex medical rescue procedures, scaffolding is not merely about simplifying tasks, but about structuring the learning environment to make complex cognitive and psychomotor processes accessible. Medical rescue operations are characterised by high stakes, significant time pressures, dynamic environments, and the need for sophisticated team coordination. These elements can generate considerable cognitive load, potentially overwhelming novice students, and hindering the development of robust skills [14].

    A scaffolded approach systematically manages this load, allowing students to focus on specific aspects of performance at different stages of their development [15]. Effective scaffolding aims to reveal the underlying causal mechanisms that constitute competent performance [16]. By providing structured support, instructors can help students identify, understand, and internalise these mechanisms, such as critical decision-making heuristics, effective communication strategies, or precise motor skills, rather than merely mimicking superficial actions [17]. The "emergence" of expert performance is thus cultivated through a carefully modulated process that respects the student's current capacities while strategically expanding them [18].

    Breaking Down Procedures: Practising Isolated Skills

    Many complex medical rescue procedures are, in reality, a concatenation of several discrete skills and decision points. Attempting to teach or practice such multifaceted procedures, holistically from the outset, can be counterproductive.

    The principle of "part-task training," a core element of scaffolding, involves deconstructing a complex skill into its constituent components, allowing students to practice and achieve mastery of these isolated elements before integrating them into a more fluid and comprehensive performance [6].

    Figure 3. offers a broad perspective of a high-angle rescue scenario, highlighting the diverse competencies, that rescue students are expected to develop. These constructs, when merged, will showcase, although simplistic and generalised, the activities that will take place during such a medical rescue operation.

    Fidelity Progression

    Low-fidelity Environment: These may involve basic rope work, like knot making or tabletop exercises. The focus is on fundamental concepts, decision-making processes, and basic procedural steps, without the distraction of highly realistic but potentially overwhelming environmental cues. For example, practising communication protocols or anchor point identification, knot making, etc. To address the multifaceted demands of modern medical rescue incidents, we developed the Visually Enhanced Mental Rescue Simulation (VEMRS) as demonstrated in Figure 4. This low-cost, highly interactive modality is an adaptation of the Visual Enhanced Mental Simulation (VEMS) methodology created for training in resource-constrained environments [19]. VEMRS deliberately shifts the focus from singular patient care to the wider operational landscape, challenging students with issues of incident command, inter-agency communication, and strategic decision-making under pressure [20]. Adopting VEMRS functions as more than a training tool; it is a research platform for identifying the deep-seated causal mechanisms, like team dynamics and communication habits, that are pivotal in determining medical rescue outcomes [21].

    Medium-fidelity Environment: These might incorporate controlled outdoor training sites capable of exhibiting physiological responses, more realistic equipment, and some environmental distractors. Students begin to integrate skills in a more contextualised manner.

    High-fidelity Environment: These are designed to closely mirror the complex and unpredictable nature of real-world situations. By incorporating authentic locations, such as mountainous terrain, these environments introduce genuine uncertainty and time pressures, requiring participants to quickly adapt. The involvement of live actor patients further increases the realism, compelling participants to integrate all necessary skills while under significant stress.

    The pursuit of authenticity, however, increases the risk of physical injury. The dynamic and uncontrolled elements present in such environments, require strong safety measures. To mitigate these risks, it is essential to conduct comprehensive risk assessments, hold mandatory safety briefings, ensure the presence of dedicated safety officers with clear authority to intervene, and establish emergency protocols. These measures are vital to guarantee that the valuable and immersive learning experience does not compromise students' well-being, balancing realism with strict safety oversight.

    Complexity Progression

    Complexity can be increased by manipulating variables such as:

    Number of Tasks: Starting with single-focus scenarios, and moving towards multi-tasking requirements.

    Information Load: Initially providing clear and unambiguous information, then introducing incomplete or conflicting data.

    Environmental Stressors: Adding background noise, weather, or challenging physical spaces.

    Team Dynamics: Progressing from individual tasks to scenarios requiring intricate interprofessional collaboration and communication.

    Patient Condition: Starting with stable patients or single pathologies and advancing to deteriorating patients with multiple co-morbidities.

     This progressive approach ensures that students are continually challenged but not excessively overwhelmed. Each stage builds upon the last, allowing for the consolidation of learning and the gradual development of resilience and adaptability. From a critical realist standpoint, the increasing complexity and fidelity seen in Figure 5. allow for the interaction of more numerous and varied causal mechanisms, providing students with insight into how these mechanisms interplay in real-world settings to produce outcomes [22]. The "geo-history" of the student, their prior experiences and learning trajectories, also informs their engagement with these progressively complex scenarios, highlighting the individualised nature of skill emergence [23].

    Principles of Scaffolding in High-Angle Medical Rescue Training

    In SBE, the concepts of fidelity and complexity progression are closely intertwined. For example, when applying scaffolding principles in high-angle rescue training, students progress from scenarios with low complexity and high levels of support to those with greater complexity and reduced support. Throughout this progression, the level of instruction, hands-on practice, and feedback is gradually adjusted to match the student’s development and needs [24].

    Basic Knot Tying and Equipment Familiarisation

    Low Complexity, High Support:

    ●       Instruction: Direct, step-by-step demonstration of each knot (e.g., figure-eight, double fisherman's) and explanation of each equipment piece (e.g., carabiners, belay devices, ascenders).

    ●       Practice: Repetitive, isolated practice of individual knots on a rope segment or familiarisation with equipment function in a low-pressure setting.

    ●       Feedback: Immediate, prescriptive correction and verification of accuracy by the instructor.

    Set Up of a Single Person Ascend and Descend Line

    Medium Complexity, Medium Support:

    ●       Instruction: Guided demonstration of how to integrate known knots and equipment (harness, descender/ascender, belay device, anchor) for personal ascent/descent.

    ●       Practice: Supervised students practice on a low, stable structure (e.g., a training tower or short wall) with redundant safety systems in place.

    ●       Feedback: Real-time coaching on body mechanics, safety checks, and procedural flow; interventions for significant errors.

    Set Up of a Basic Mechanical Advantage System

    Medium Complexity, Medium Support:

    ●       Instruction: Explanation of principles of mechanical advantage (e.g., 3:1, 5:1 systems) and demonstration of combining rope, pulleys/carabiners, and anchors to build a simple system.

    ●       Practice: Team-based exercises to assemble and operate the system with a non-critical load (e.g., a rescue dummy) on flat ground or a gentle slope.

    ●       Feedback: Focus on correct rigging, load management, and team communication; troubleshooting common issues as they arise.

    Apply Medical Rescue Techniques to Different and Novel Environments

    High Complexity, Low Support:

    ●       Instruction: Scenario-based briefings with minimal direct instruction on specific techniques; emphasis on problem-solving and adaptation.

    ●       Practice: Full-scale exercises in varied, less predictable environments (e.g., multi-story structures, natural rock faces, confined spaces) with complex scenarios and potential stressors (e.g., noise, limited visibility).

    ●       Feedback: Instructor primarily observes, intervenes only for critical safety concerns, and facilitates comprehensive debriefings focused on decision-making, risk assessment, team coordination, and adaptive problem-solving under pressure. Students are encouraged to self-assess and provide peer feedback.

    This allows students to develop the specific motor skills and cognitive understanding required for each step without the immediate pressure of managing the entire scenario. Once proficiency in these isolated skills is demonstrated, they can be progressively chained together. This methodical approach ensures that foundational competencies are robustly established, which is critical for the successful "emergence" of the more complex, integrated skill. The "absence" of a specific foundational skill can lead to cascading failures in a real-world medical rescue operation; isolated practice helps identify and remediate such potential absences early in the MRS process. This aligns with a critical realist emphasis on understanding how component parts (mechanisms) contribute to the functioning (or dysfunctioning) of the whole system [25].

    Progressive Scenario Design: From Low to High Fidelity and Complexity

    Effective scaffolding in SBE extends beyond individual skills to the overall design of MRS scenarios. Progressive scenario design involves a deliberate and incremental increase in both the fidelity and complexity of MRS as students advance [26].

    Techniques for Effective Scaffolding (Micro-level)

    Beyond the macro-level design of curricula and scenarios, effective scaffolding relies on specific techniques employed by instructors during the MRS and debriefing phases. These micro-level interactions provide crucial real-time support and guidance [27].

    Clear Pre-briefing: Before a scenario begins, instructors must clearly articulate the learning objectives, the expected level of performance, the available resources, and the degree of support that will be offered. This manages student expectations and focuses their attention [28].

     Thinking Aloud: Encouraging students to verbalise their thought processes during a scenario can provide instructors with insights into their decision-making and allow for timely, targeted guidance. It also helps students to self-monitor and reflect-in-action [29].

     Prompting and Cueing: When students encounter difficulties, instructors can provide subtle hints, questions, or direct cues to guide them towards appropriate actions or considerations. This might involve drawing attention to a critical piece of data or suggesting a potential intervention. The level of prompting should be inversely proportional to the student's developing expertise [30].

     Structured Feedback: Providing specific, objective, and constructive feedback, both during (if appropriate and aligned with the scaffolding strategy) and after the scenario, is essential. This feedback should focus on observed behaviours and their consequences, linking them to the underlying principles and mechanisms of effective care [31, 32].

     Pause and Discuss: In some instances, particularly during formative learning, it can be beneficial to temporarily pause the MRS to discuss a critical decision point, clarify a misunderstanding, or reinforce a teaching point before resuming the scenario [33].

     Gradual Withdrawal of Support (Fading): As students demonstrate increased competence and confidence, the instructor systematically reduces the level of prompting, cueing, and direct intervention. This encourages greater autonomy and allows students to take fuller ownership of the problem-solving process [30].

     Effective Debriefing: The post-scenario debriefing is a cornerstone of SBE and a critical component of scaffolding. Instructors should guide a reflective discussion that encourages students to explore not only what happened, but why it happened and how it could be improved. This involves examining the causal chains of events, the decisions made (and their rationales), and the impact of team interactions [34]. An informed debriefing might explicitly probe the interplay of contextual factors, individual actions, and underlying mechanisms that shaped the scenario's outcomes [35]. These micro-level techniques, when skilfully applied, create a dynamic and responsive learning environment that supports students in navigating complex challenges and internalising the deep structures of proficient medical rescue practice [27].

     Scaffolding complex medical rescue procedures through SBE is a powerful pedagogical strategy that aligns with the demands of preparing TRS for high-stakes environments. By systematically breaking down procedures, progressively designing scenarios from low to high fidelity and complexity, and employing effective micro-level support techniques, instructors can create pathways for students to develop the robust, adaptable competencies required in medical rescue. This approach not only fosters the emergence of proficient performance but also cultivates a deeper understanding of the causal mechanisms that underpin successful outcomes in medical rescue situations. Such a structured, yet adaptable, pedagogical framework is indispensable for programmes aiming to produce critically thinking and highly capable TRS.

    Conclusion

    The systematic scaffolding of complex medical rescue procedures, through deliberate progression in simulation fidelity and task complexity, alongside the decomposition of procedures into discrete, manageable skills, effectively mitigates cognitive and psychomotor overload. This structured approach facilitates the incremental development of proficiency, enabling learners to build upon foundational competencies in a manner that supports the emergence of expert performance.

    While the broader framework of MRS encompasses four interconnected pillars, this article has primarily focused on the pedagogical dimensions of foundational learning theory, and systematic skill scaffolding as critical drivers of effective SBE. The remaining pillars, which are integrated physical preparedness and stringent safety protocols, although acknowledged as essential to the holistic development of TRS, were not the central focus of this article. Their roles in ensuring physical readiness and safeguarding psychological and physical well-being warrant dedicated exploration in future work.

    By emphasising the theoretical and instructional foundations of simulation, this article contributes to the advancement of evidence-informed practices in medical rescue training. Institutions committed to producing competent, resilient, and critically thinking TRS must adopt such structured and theory-driven approaches to SBE, ensuring that learners are equipped not only with technical expertise, but also with the cognitive agility required to navigate the complexities of real-world emergencies.

    Author contributions
    All authors contributed equally and validated the final version of record.
    Declarations
    Conflicts Of Interests
    The Authors declare that there is no conflict of interest.
    Funding
    This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
    Registration
    No registration applicable.
    Data availability statement
    The data that support the findings of this study are available from the corresponding author upon reasonable request.
    Ethical approval
    Ethical approval for this study was not required.

    References

    1.      Hooshangi N, Mahdizadeh Gharakhanlou N, Ghaffari-Razin SR. Urban search and rescue (USAR) simulation in earthquake environments using queuing theory: estimating the appropriate number of rescue teams. Int J Disaster Resil Built Environ. 2024;15(1):1‒18. https://doi.org/10.1108/IJDRBE-09-2021-0122

    2.      Elendu C, Amaechi DC, Okatta AU, Amaechi EC, Elendu TC, Ezeh CP, et al. The impact of simulation-based training in medical education: a review. Medicine (Baltimore). 2024;103(27):e38813. https://doi.org/10.1097/MD.0000000000038813

    3.      Secheresse T, Pansu P, Lima L. The impact of full-scale simulation training based on Kolb’s learning cycle on medical prehospital emergency teams: a multilevel assessment study. Simul Healthc. 2020;15(5):335‒340. https://doi.org/10.1097/SIH.0000000000000461

    4.      Wijnen-Meijer M, Brandhuber T, Schneider A, Berberat PO. Implementing Kolb’s experiential learning cycle by linking real experience, case-based discussion and simulation. J Med Educ Curric Dev. 2022;9:23821205221091510. https://doi.org/10.1177/23821205221091511

    5.      Smith M. Experiential learning experiences of emergency medical care students at a selected University in KwaZulu-Natal [Dissertation for the Degree of Master of Health Sciences]. [Durban, South Africa]: Durban University of Technology; 2018. https://doi.org/10.51415/10321/3093

    6.      Taraporewalla K. The Adaptation of Motor Learning Theory in Medical Procedural Tasks [PhD Thesis]. Faculty of Medicine, The University of Queensland; 2024. https://doi.org/10.14264/ea20136

    7.      Zawawi AA, Halim NA, Kamarunzaman NZ, Zawawi AA, Halim FW. The linkage between team communication, team motivation and search and rescue team performance. SA J Hum Resour Manag. 2023;21:10. https://doi.org/10.4102/sajhrm.v21i0.2217

    8.      Chernikova O, Heitzmann N, Stadler M, Holzberger D, Seidel T, Fischer F. Simulation-based learning in higher education: a meta-analysis. Rev Educ Res. 2020;90(4):499‒541. https://doi.org/10.3102/0034654320933544

    9.      Chan CKY, Lee KKW. Reflection literacy: a multilevel perspective on the challenges of using reflections in higher education through a comprehensive literature review. Educ Res Rev. 2021;32:100376. https://doi.org/10.1016/j.edurev.2020.100376

    10.  Abdullah N, Rose J, Brown E, Geduld H. Vehicle extrication in road traffic crashes: a descriptive analysis of an advanced medical rescue service in South Africa. Afr J Emerg Med. 2025;15(2):621‒7. https://doi.org/10.1016/j.afjem.2025.04.003

    11.  Altmiller G, Pepe LH. Influence of technology in supporting quality and safety in nursing education. Nurs Clin North Am. 2022;57(4):551‒62. https://doi.org/10.1016/j.cnur.2022.06.005

    12.  Shabani K, Khatib M, Ebadi S. Vygotsky’s zone of proximal development: instructional implications and teachers’ professional development. English Lang Teach. 2010;3(4):237. https://doi.org/10.5539/elt.v3n4p237

    13.  Sellberg C, Mona L, Saljo R. Assessment in the zone of proximal development: simulator-based competence tests and the dynamic evaluation of knowledge-in-action. Classroom Discourse. 2022;13(4):365‒85. https://doi.org/10.1080/19463014.2021.1981957

    14.  Esmaeili R, Yazdi M, Rismanchian M, Shakerian M. Unveiling the dynamics of team cognition in emergency response teams. Front Psychol. 2025;16:1534224. https://doi.org/10.3389/fpsyg.2025.1534224

    15.  Masava B, Nyoni CN, Botma Y. Scaffolding in health sciences education programmes: an integrative review. Med Sci Educ. 2023;33(1):255‒73.  https://doi.org/10.1007/s40670-022-01691-x

    16.  Stutchbury K. Critical realism: an explanatory framework for smallscale qualitative studies or an ‘unhelpful edifice’? Int J Res Method Educ. 2022;45(2):113‒28. https://doi.org/10.1080/1743727X.2021.1966623

    17.  Thornhill-Miller B, Camarda A, Mercier M, Burkhardt J-M, Morisseau T, Bourgeois-Bougrine S, et al. Creativity, critical thinking, communication, and collaboration: assessment, certification, and promotion of 21st century skills for the future of work and education. J Intell. 2023;11(3):54. https://doi.org/10.3390/jintelligence11030054

    18.  Sobuwa S. A critical realist study into the emergence and absence of academic success among Bachelor of Emergency Medical Care students [Doctoral Thesis]. University of Cape Town; 2018. Available from: http://hdl.handle.net/11427/29475

    19.  Alinier G, Meyer J, Naidoo V, Campbell C. Simplifying simulated practice for healthcare professionals and educators. J Emerg Med Trauma Acute Care. 2016;2016(2):1. https://doi.org/10.5339/jemtac.2016.icepq.79

    20.  Dogan B, Pattison N, Alinier G. A form of mental simulation with significant enhancements enabling teamwork training. Int J Healthc Simul. 2021;1(1):56‒60. https://doi.org/10.54531/JSHC9951.

    21.  Brazil V, Speirs C, Scott C, Schweitzer J, Purdy E. Recommendations for the design and delivery of visually enhanced mental simulation: insights from participants and facilitators. J Healthc Simul. 2025;1‒11. https://doi.org/10.54531/NDXV6633

    22.  Swart R, Duys R, Hauser ND. SASS: South African Simulation Survey ‒ a review of simulation-based education. S Afr J Anaesth Analg. 2019;25(4):12‒20.

    23.  Khalid AF, George MA, Eggen C, Sritharan A, Wali F, Viens AM. Using Simulation-Based Experiential Learning to Increase Students’ Ability to Analyze Increasingly Complex Global Health Challenges: A Mixed Methods Study. medRxiv. 2023 Jan 1;2023.12.19.23300262. https://doi.org/10.1101/2023.12.19.23300262

    24.  Bauer E, Heitzmann N, Fischer F. Simulation-based learning in higher education and professional training: approximations of practice through representational scaffolding. Stud Educ Eval. 2022;75:101213. https://doi.org/10.1016/J.STUEDUC.2022.101213

    25.  Owen JR, Kemp D, van der Watt P, Harris J, Li Ern Ang M, Marais L. Disaster scenes as a foundation for emergency response planning. Int J Disaster Risk Reduct. 2024;113:104795. https://doi.org/10.1016/j.ijdrr.2024.104795

    26.  Fraser KL, Ayres P, Sweller J. Cognitive load theory for the design of medical simulations. Simul Healthc. 2015;10(5):295. https://doi.org/10.1097/SIH.0000000000000097

    27.  Masava B, Nyoni CN, Botma Y. Standards for scaffolding in health sciences programmes: a Delphi consensus study. J Med Educ Curric Dev. 2023;10:23821205231184045. https://doi.org/10.1177/23821205231184045

    28.  Hughes PG, Hughes KE. Briefing prior to simulation activity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31424818

    29.  Abdulmohdi N, McVicar A. Investigating the clinical decision-making of nursing students using high-fidelity simulation, observation and think aloud: a mixed methods research study. J Adv Nurs. 2023;79(2):811‒24. https://doi.org/10.1111/JAN.15507

    30.  Poledna M, Gomez-Morales A, Hagler D. Nursing students’ cue recognition in educational simulation: a scoping review. Nurse Educ. 2022;47(5):283‒7. https://doi.org/10.1097/NNE.0000000000001198

    31.  Ludeke AK, Olaya JFG. Effective feedback, an essential component of all stages in medical education. Universitas Medica. 2020;61(3):1‒15. https://doi.org/10.11144/Javeriana.umed61-3.feed

    32.  Ajjawi R, Bearman M, Molloy E, Noble C. The role of feedback in supporting trainees who underperform in clinical environments. Front Med (Lausanne). 2023;10:1121602. https://doi.org/10.3389/fmed.2023.1121602

    33.  Lee JY, Szulewski A, Young JQ, Donkers J, Jarodzka H, van Merrienboer JJG. The medical pause: importance, processes and training. Med Educ. 2021;55(10):1152‒60. https://doi.org/10.1111/medu.14529

    34.  Decker S, Alinier G, Crawford SB, Gordon RM, Jenkins D, Wilson C. Healthcare Simulation Standards of Best Practice™: the debriefing process. Clin Simul Nurs. 2021;58:27‒32. https://doi.org/10.1016/j.ecns.2021.08.011

    35.  Abulebda K, Auerbach M, Limaiem F. Debriefing techniques utilized in Medical Simulation. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31536266

     

  • Knowledge and Stigma Regarding HIV and Homosexuality: An Exploratory Survey of Responding Physicians in Lebanon

    Background
         HIV remains a major public health challenge in the Middle East and North Africa (MENA), where stigma against people with HIV (PWH) and men who have sex with men (MSM) hinders access to care. In Lebanon, little is known about physicians’ current knowledge, attitudes, and willingness to provide care for PWH.
    Methods
         We conducted an exploratory online survey of all Lebanese physicians registered with the Ministry of Public Health, distributed in four waves between 2023 and 2025. The 58-item questionnaire assessed HIV knowledge, attitudes toward PWH and homosexual colleagues, willingness to provide medical care, and practices related to sexual history and pre-exposure prophylaxis (PrEP). Out of 4,331 emails, 760 were invalid and 127 physicians responded (3.2%).

    Results
         Interpretation is limited by a low response rate, and findings should be  considered for hypothesis generation rather than prevalence estimates.  Respondents were mostly male (63%), with varied specialties and practice
    settings. Knowledge of HIV transmission was generally high, though gaps were identified: 54% did not recognize breastmilk as a transmission route, 20% were unaware of confidential testing facilities, and only 64% knew that PrEP prevents transmission. While 86% were willing to medically examine PWH and over 90% would perform minor or major procedures, 29% believed physicians have the right to refuse care due to fear of infection. Stigmatizing attitudes were also noted, where 13% would not buy food from PWH, 33% would not allow their child
    to play with PWH, and 39% would not accept surgery from a surgeon living with HIV. Regarding homosexuality, 10–12% opposed accepting homosexual applicants to medical training or granting them practicing privileges. Most respondents (61%) did not routinely take sexual histories, and 84% had never prescribed PrEP, while 96% agreed on the need for further education.

    Conclusion
         In this exploratory sample, respondents had adequate HIV knowledge, but signs of stigma and prevention gaps (PrEP/sexual history) were identified toward PWH and homosexual colleagues, coupled with significant gaps in awareness of PrEP and HIV testing. Physician-targeted educational campaigns focusing on transmission, PrEP, and non-discrimination may help reduce barriers to HIV care and align Lebanon with WHO’s goal of ending the epidemic.

    INTRODUCTION
         As of 2025, HIV remains one of the longest on-going pandemics [1]. Affecting diverse populations, different areas of the world deal with it differently [2]. Thus, the barriers to HIV care tend to be unique to certain areas of the world, dictated by the prevalence of certain modes of transmission, access to care, availability and cost of medication, ease of diagnosis, lack of awareness and stigma and social barriers [3]. As of 2019, the United Nations Programme on HIV/AIDS (UNAIDS) reported a 95% surge in HIV incidence in the Middle East and North Africa (MENA) region [4]. With a high proportion of new infections occurring in the population of men who have sex with men (MSM) [5], these populations face a lot of stigma and stereotype that challenges their access to HIV-related care. In addition, insurances are able to legally refuse and deny coverage for a person living with HIV (PWH) [6]. Moreover, not all Lebanese physicians are willing to assess PWH or people belonging to the Lesbian/Gay/Bisexual/Transsexual+ (LGBT+) community [7]. These people often face discrimination when seeking medical care, which can
    root from discrimination or lack of proper training due to excessive stigma [8].

         With the Lebanese Ministry of Public Health (MoPH), the National AIDS Control Program and the local NGOs, awareness was improved and medication was provided for free, in an attempt to improve sexual health, prevention and HIV care [9]. There was a decrease of 52% in HIV incidence in 2020 [10]. However, despite
    evidence of continued transmission during coronavirus lockdown years [11], little data exists about the progress related to stigma and awareness, especially with a big outflow of physicians and an economic crisis [12].

         Among the tools available to assess physicians’ perspective on this matter, surveys provide valuable data, but they are challenged by low response rates, leading to selection bias [13, 14]. Despite these challenges, nationwide surveys provide very meaningful exploratory information in such settings in the most cost-effective way [15].

         To assess the current situation, we conducted an exploratory survey sent to all registered Lebanese physicians to assess their attitudes towards HIV and homosexuality as well as their knowledge about HIV. This would provide a descriptive assessment of the current situation amongst Lebanese providers and their current willingness to engage, treat and assist in the care of PWH in  Lebanon. As we have little data regarding this area in Lebanon, recording such
    responses would provide valuable information about the nature of the situation and help identify areas to focus efforts for future intervention for a more effective approach towards the World Health Organization (WHO) goals to ending the HIV epidemic.

         Emergency and acute care settings are usually the first point of contact for people with undiagnosed HIV, patients presenting after occupational exposure or sexual assault, and those requiring urgent interventions. Physician knowledge of HIV transmission risk, comfort with procedural care, and familiarity with HIV  prevention strategies affect patient safety, occupational safety, and equity of care.

    METHODS
         Analyses were planned as primarily descriptive given the exploratory study design and anticipated low response rate.

         To assess the current attitudes of Lebanese physicians towards PWH and homosexual patients, we conducted an online survey that was sent to all
    registered Lebanese physicians via email, in 4 waves between 2023 and 2025.

         The survey consisted of 58 multiple-choice questions regarding HIV  transmission awareness, attitude towards PWH, experience and willingness to
    provide medical care to PWH, healthcare professionals living with HIV and colleagues who are homosexual and sexual history and pre-exposure prophylaxis (PrEP).

         The 58-item instrument was developed for exploratory use based on domains relevant to HIV care and stigma (transmission knowledge, willingness to provide care/procedures, occupational exposure/PEP/PrEP awareness, sexual history  practices, and attitudes toward colleagues). Items were reviewed by the study team for clarity and validity prior to distribution. The questionnaire was not  normally psychometrically validated.

         We used a registry of emails provided by the Lebanese AIDS Society which  contains emails of all registered Lebanese physicians in the MoPH as of 2019. This yielded 4331 email addresses. A special email address was used to send the IRB-approved email template containing the google docs link to the survey.

         Out of the email addressed contacted, 760 addressed were unreachable due to a wrong, inactive or outdated address. The remaining 3571 addresses received all 4 email invitations, which yielded 127 (3.2%) responses.

         Given the low response rate, results are subject to nonresponse and selection bias, and are presented as exploratory findings rather than population estimates.

    STATISTICAL ANALYSIS
         Responses were summarized using counts and percentages. Given the exploratory design and limited sample size, we restricted analyses to descriptive statistics and bivariate comparisons. Associations between physician characteristics and outcomes related to HIV stigma and prevention were explored by chi-square or Fisher’s exact tests, as appropriate. Univariable logistic regression was performed to estimate odds ratios (ORs) with 95% confidence intervals when possible. No multivariable modeling was planned. All analyses were considered hypothesis-generating, and p-values were interpreted descriptively without adjustment for multiple comparisons.

    ETHICS
         This project was reviewed and granted approval by the Lebanese American University Institutional Review Board. All survey answers were kept anonymous.

    RESULTS
         Out of the 127 responses, 81 (63%) were male, 12 (9.4%) graduated before 1989, 19 (15%) between 1990 and 1999, 44 (35%) between 2000 and 2009 and 52 (41%) after 2010. Among respondents, 81 (64%) graduated from Lebanese private universities, 25 (19.6%) graduated from the Lebanese University and 20 (15.7%) graduated from outside Lebanon. They practiced in different specialties, with family medicine, pediatrics, anesthesiology, obstetrics and gynecology and infectious diseases being the most reported specialties reported. Regarding studies, 94 (74%) of respondents reported to have studied abroad at some point in their careers, and 75 (59%) of them reported practicing medicine at some point outside Lebanon. As for practice, 77 (60.6%) reported practicing in a university medical center and 64 (50.3%) reported engaging in teaching activities at least 2 times weekly. 93 (73.2%) of them reported seeing on average more than 10 patients per day.

    Questions regarding HIV and transmission awareness
         The vast majority (125; 98.4%) of respondents knew HIV cannot be transmitted by sharing eating and drinking utensils or by sharing towels and toilets with PWH. Regarding other sexually transmitted infections (STIs) like gonorrhea and genital herpes, 88 (69.2%) of respondents knew they increase the likelihood of HIV transmission if untreated. For vertical transmission, 111 (87.4%) knew a mother with HIV can have an uninfected baby. However, 69 (54.3%) respondents did not know that HIV can be transmitted to the baby by breastmilk. As for routine antibody-based testing, 114 respondents (89.7%) were certain these tests are not able to detect HIV antibodies within a few days of infection, and 25 (19.7%) of respondents did not know there are facilities in Lebanon that provide confidential testing. Furthermore, 3 (2.3%) physicians responded that they can tell if someone is a PWH by their appearance. 108 (85%) responded that antiretroviral therapy (ART) prolongs the life of PWH, and 81 (64%) knew that oral PrEP is effective in HIV prevention.

    Questions regarding general attitude towards PWH
         When asked about interactions with PWH, 9 (7%) respondents did not agree to go to a store owned by a PWH, 17 (13.3%) did not agree to buy food from a PWH, 42 (33.1%) did not agree to let their child play with a PWH, 19 (15%) did not agree to play sports with someone with HIV, 16 (12.6%) were reluctant to accept a dinner invitation from a friend living with HIV and 2 (1.6%) thought that PWH should be isolated.

    Questions regarding experience and willingness to provide medical care to PWH
         When it came to experience with PWH, 89 (70.1%) of respondents have treated a PWH at some point in their careers, and 122 (86.1%) of them expressed willingness to medically examine a PWH. If that person is a relative, 117 (92.1%) were willing to medically care for them. When asked if they were willing to perform minor procedures on PWH, such as venipuncture, abscess drainage, mole excision, chest tube placement, 81 of the 87 (93.1%) eligible respondents expressed willingness to do so, and with open surgery, 56 of the 60 (93.33%) eligible respondents were willing to do so. A third of respondents (37, 29.1%) agreed that physicians have the right to refuse medical care to PWH for fear of contamination.

    Questions regarding healthcare professionals living with HIV and colleagues who are homosexual
         Among the physicians who responded to the survey, 12 (9.4%) reported they would not accept to be treated by a doctor who lives with HIV, and 50 (39.4%) reported not accepting to be operated on by a surgeon living with HIV. While 124 (97.6%) expressed willingness to get tested for HIV if exposed, 22 (17.3%) have never been tested before.

         Regarding colleagues with HIV, 15 respondents (11.8%) were unwilling to refer patients to a colleague with HIV, 9 (7.%) think a colleague who gets infected with HIV should not be allowed to continue working and 15 (11.8%) think a qualified applicant with HIV should not be admitted to medical school or residency programs.
         Regarding homosexuality, 15 (11.8%) would not refer a patient to a colleague who is homosexual, 13 (10.2%) think such a colleague should be denied practicing privileges and 12 (9.4%) think a qualified applicant who is homosexual should not be admitted to medical school or residency programs.

    Questions regarding sexual history and PrEP
         Most respondents (78, 61.4%) did not take sexual history in their routine history taking, and 107 (84.2%) had never prescribed PreP. Furthermore, 61 (48%) expressed unwillingness to prescribe it for someone with high risk of HIV infection, and 62 (49%) believed it will decrease safe sex practices and increase the incidence of STIs. Similarly, 23 (18.1%) would not advise an exposed colleague to start PrEP, and 44 (34.6%) believed PreP will cause ART resistance. The majority of respondents (122, 96.1%) believed more education around PrEP should be implemented before prescribing it routinely.

    Exploratory Association Analyses
         We performed exploratory bivariate analyses to assess if certain physician characteristics were associated with stigma and prevention outcomes. No statistically significant associations were observed for routine sexual history taking, PrEP prescribing, belief in the right to refuse care, or willingness to accept surgery from a surgeon/dentist living with HIV (all p>0.05). Univariable logistic regression similarly did not identify significant predictors; however, there was a trend toward lower refusal of surgery among physicians who had studied abroad (OR 0.51, 95% CI 0.23–1.14; p=0.10).

    DISCUSSION
         While we had different demographic profiles of respondents, most younger graduates, who work in educational institutions and had some international experience with a big patient load. This coincides with the known profile of physicians who are more likely to respond to survey invitations, are they are more familiar with such an approach [16]. Furthermore, such profiles are generally more accepting and less stigmatizing of patient populations, due to general and educational trends, making them more inclined to answer surveys related to stigma around HIV and homosexuality [17, 18].

         In general, our exploratory survey showed a high awareness of the general knowledge about HIV transmission and the safety of sharing utensils and toilets with PWH, which is a good baseline. This situation is better than the 1990s, where PWH were discriminated against because of misinformation around this topic. Back then even nurses would not enter the rooms of PWH and they would be left alone, stigmatized, and quarantined [19].

         However, our results show significant gaps in knowledge around HIV transmission and its interaction with other STIs. Only 69% of respondents knew that untreated gonorrhea and herpes increase HIV transmission risk, and around 46% not being sure or not knowing that HIV can be transmitted via breastmilk might be indicators of an awareness gap, worthy of a focused intervention in future campaigns.

         Furthermore, around 10% of respondents were not certain about antibody testing windows and 20% were not aware of confidential testing facilities. These can be barriers to effective testing, where some PWH might not know their status. In addition, while 85% of provider respondents knew that ART prolongs life or PWH, only 65% of them knew PrEP is effective in prevention, which can be an awareness gap to target for future campaigns.

         While a small number, still having some providers think they can tell PWH by appearance and that they should be quarantined, is a significant indicator that stigma and misinformation are not fully eradicated, even among physicians. This is especially evident in a quantifiable stigma attitude towards PWH, which ranges from somewhere around 7% with minimal interaction (buying groceries from shopper) to around 33% when a respondent’s child is playing with a PWH. The 1996-2004 Lebanese study showed a gap between HIV awareness and declining knowledge in prevention and safe practices. When this stigma is not eradicated, even among physicians, this can impede public health interventions. This shows there is a multi-layered problem where misinformation not only affects the general public, but also some healthcare providers [20].

         However, when it comes to providing care, the general trend was positive, with more than 85% of respondents willing to examine PWH or caring for relatives with HIV and performing minor procedures or surgeries on them. This can represent an improvement from the 50-50 willingness of physician care for PWH in 2014(7). Nevertheless, 29% of them agreeing that physicians have the right to refuse care for PWH because of fear of contamination might be a point to target in future campaigns to stress on non-transmissibility of the virus in treated PWH with controlled viral loads [21]. This hesitation is concerning in emergency departments, where delays in triage or refusal of urgent procedures due to fear of transmission can impact patient morbidity [22]. Therefore, more education about basic infection control barriers and their effectiveness in prevention of any blood-borne illness prevention should always be implemented, especially that most patients are not routinely tested for HIV. If all barriers fail and a needlestick injury happens, post-exposure prophylaxis, or PEP, is available and effective [23].

         This remains better than the situation in the 1990s, where physicians and dentists in the west would deny PWH care due to fear of the infection and of stigma, despite effective treatment emergence [24].

         Furthermore, the percentages of respondents who discriminate against medical (9.4%) or surgical (39.4%) colleagues with HIV was alarming. Their unwillingness to refer patients to colleagues who live with HIV (11.8%), and similar percentages of respondents thinking colleagues with HIV or who are homosexual should be denied practicing privileges or prevented from admission to medical school or residency programs shows some clear discriminatory points in the medical community against PWH and LGBT+ people.

         Regarding sexual history taking and PrEP, having 61% of respondents admitting to not routinely taking sexual history shows possible missed opportunity for detecting new exposure and preventing new infection. However, 84% of respondents have never prescribed PrEP and 48% are not willing to do so with one-third of them lack up-to-date knowledge about its use or safety.

         Surveys responses can be low, sometimes less than 5%, especially in uncompensated surveys as in our case. 13 Physician surveys are especially known to have low response rates [25]. Furthermore, the coronavirus pandemic induced a “survey fatigue”, further decreasing response rates [26]. Some invitations would have been lost in the high volume of emails received daily by physicians. Furthermore, since there is no perceived benefit from filling the surveys, many would have just ignored the invitation [13, 27, 28]. The financial crisis and general stress and burnout would be demotivating to fill a survey, and the outflow of physicians to outside the country means that many of them might have abandoned the previously registered email accounts. Moreover, it is impossible for us to know with certainty the number of active email addresses in the registry, so our calculated 3.2% response rate might be an underestimation of the actual rate of response from physicians who received the invitation and filled the survey. Therefore, percentages in this study should be interpreted as signals among respondents, not as estimates of stigma prevalence among Lebanese physicians overall.

         This low response rate would lead to a selection and a nonresponse bias, which affects data representativeness and accuracy. However, the exploratory nature of this study in a topic that is stigmatized and faced with the obstacles mentioned makes our findings important. While our study was not made to draw generalizable conclusions, it aims to gain insight into the current situation among physicians, providing us with potential areas of focus for future interventions in the country to mitigate challenges PWH face while seeking healthcare.

         These results would help us make some recommendations for prevention efforts against HIV in Lebanon in the coming years based on the possible gaps identified in our exploratory survey. These recommendations would be for awareness campaigns targeted for physicians practicing medicine in Lebanon. Based on these findings, we recommend that future educational campaigns for Lebanese physicians prioritize three areas. First, interventions must correct persistent misconceptions regarding horizontal transmission and teach the concept that Undetectable = Untransmissible (U=U) to reduce refusal of care. Second, training should focus on practical protocols regarding indications for PrEP, the window periods for different HIV tests, and the availability of confidential testing sites. Finally, to ensure occupational safety and reduce delays in procedures, education should include efficacy of PEP following needle-stick injuries, ensuring that fear of contamination does not compromise urgent surgical or emergency interventions.

    LIMITATIONS
         Our study has some limitations, especially its low response rate. This is mitigated by the exploratory nature of the study. The questionnaire was not pilot-tested or psychometrically validated, which may affect reliability and comparability across studies. In addition, the list of emails used was from 2019, which was largely due to the unavailability of a more updated list after the COVID-19 pandemic. As a lot of physicians left Lebanon after the pandemic, this can be a contributing factor to the low response rate.

    CONCLUSION
         With stigma and misinformation affecting the public and healthcare professionals regarding HIV and homosexuality in Lebanon, it is important to identify areas of actionable concern. This exploratory survey revealed knowledge gaps, especially in PrEP use, HIV testing and transmission. In general, physician-targeted campaigns on HIV awareness regarding transmission, screening, testing, availability of confidential testing sites, PrEP and PEP might play a role in promoting acceptance, especially in the emergency department. These targeted campaigns, identified by our survey, might be very promising in changing Lebanese physicians’ attitudes towards HIV in Lebanon, and subsequently their attitude towards homosexuality. This would lead to more testing, more treatment and more viral control, contributing eventually to the WHO goals to end HIV.

    Author contributions
    All authors contributed equally and validated the final version of record.
    Declarations
    Conflicts Of Interests
    The Author declares that there is no conflict of interest.
    Funding
    This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
    Registration
    No registration applicable.
    Data availability statement
    The data that support the findings of this study are available from the corresponding author upon reasonable request.
    Ethical approval
    This project was reviewed and granted approval by the Lebanese American University Institutional Review Board. All survey answers were kept anonymous.

    References

    1.           A Timeline of HIV and AIDS. HIV.gov. Accessed May 12, 2025. https://www.hiv.gov/hiv-basics/overview/history/hiv-and-aids-timeline

    2.           Global Statistics. HIV.gov. Accessed May 12, 2025. https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics

    3.           Sambayi GL, Bwire GM, Kilapilo MS, Myemba D, Mosha IH, Kilonzi M, et al. Barriers and Enablers to Retention in HIV Care and Adherence to Antiretroviral Therapy: Evidence from Dar es Salaam, Tanzania. HIV AIDS (Auckl). 2024 Jul 26;16:301–311. https://doi.org/10.2147/HIV.S458545

    4.           Assi A, Abu Zaki S, Ghosn J, Kinge N, Naous J, Ghanem A, et al. Prevalence of HIV and other sexually transmitted infections and their association with sexual practices and substance use among 2238 MSM in Lebanon. Sci Rep. 2019 Oct 22;9(1):15142. https://doi.org/10.1038/s41598-019-51688-7

     

    5.           Country progress report - Lebanon [Internet]. Global AIDS Monitoring 2020;  Accessed May 12, 2025. https://www.unaids.org/sites/default/files/country/documents/LBN_2020_countryreport.pdf

    6.           Berk E. Viral Subjects: Stigma, Civil Society Activism, and the Making of HIV/AIDS in Lebanon [Internet] [PhD dissertation]. Yale Graduate School of Arts and Sciences; 2021. Available from: https://elischolar.library.yale.edu/gsas_dissertations/303

     

    7.           Abdessamad HM, Fattal O. Lebanese Medical Association for Sexual Health: Advancing Lesbian, Gay, Bisexual, and Transgender Health in Lebanon. LGBT Health. 2014;1(2):79–81. https://doi.org/10.1089/lgbt.2013.0039

    8.           Daoud Khatoun W, Slim A, Makhlouf J, Lau SSS, Cheng MCH, Chebat A, et al. Health conditions, health literacy, access to care, and health care experiences among lesbian, gay, bisexual, transgender and queer adults in Lebanon. International Journal for Equity in Health. 2025 Apr 7;24(1):95. https://doi.org/10.1186/s12939-025-02417-2

     

    9.           National AIDS Control Program. National HIV Strategic Plan 2023-2028 [Internet]. Ministry of Public Health of Lebanese Republic; 2025. Available from: https://www.moph.gov.lb/userfiles/files/Prevention/NationalAIDSControlProgram/National%20HIV%20Strategic%20Plan%202023-2028_Final.pdf

     

    10.        WHO - Regional Office for the Eastern Mediterranean. World Health Organization. [cited 2025 May 12]. Lebanon HIV/AIDS country profile 2020. Available from: http://www.emro.who.int/asd/country-activities/lebanon.html

    11.        STI & HIV 2023 World Congress [Internet]. American Sexually Transmitted Diseases Association; [cited 2025 May 12]. Available from: https://stihiv2023.org/

     

    12.        Bou Sanayeh E, El Chamieh C. The fragile healthcare system in Lebanon: sounding the alarm about its possible collapse. Health Econ Rev. 2023;13(1):21. https://doi.org/10.1186/s13561-023-00435-w

     

    13.        Ellis LA, Pomare C, Churruca K, Carrigan A, Meulenbroeks I, Saba M, et al. Predictors of response rates of safety culture questionnaires in healthcare: a systematic review and analysis. BMJ Open. 2022 Sep 1;12(9):e065320. https://doi.org/10.1136/bmjopen-2022-065320

     

    14.        American Medical Association [Internet]. 2018 [cited 2025 May 13]. 3 legitimate concerns about patient-experience surveys. Available from: https://www.ama-assn.org/delivering-care/ethics/3-legitimate-concerns-about-patient-experience-surveys

     

    15.        American Medical Association [Internet]. 2017 [cited 2025 May 13]. How physician surveys impact major issues. Available from: https://www.ama-assn.org/delivering-care/public-health/how-physician-surveys-impact-major-issues

    16.        Larson N, Neumark-Sztainer D, Harwood EM, Eisenberg ME, Wall MM, Hannan PJ. Do young adults participate in surveys that ‘go green’? Response rates to a web and mailed survey of weight-related health behaviors. Int J Child Health Hum Dev. 2011;4(2):225-231.

    17.        GLAAD [Internet]. New York; 2023 [cited 2025 May 14]. GLAAD releases fourth annual HIV stigma study. Available from: https://glaad.org/releases/glaad-releases-fourth-annual-hiv-stigma-study/

     

    18.        Ghanem CA, El Khoury C, Mutchler MG, Ghosh-Dastidar B, Kegeles S, Balan E, et al. Gay Community Integration as Both a Source of Risk and Resilience for HIV Prevention in Beirut. Int J Behav Med. 2020 Apr 1;27(2):160–9. https://doi.org/10.1007/s12529-019-09829-9

     

    19.        Abdelnour R. A silent history: The AIDS epidemic in Lebanon. L’Orient Today [Internet]. 2023 Apr 26 [cited 2025 May 14]; Available from: https://today.lorientlejour.com/article/1335673/a-silent-history-the-aids-epidemic-in-lebanon.html

     

    20.        Kahhaleh, JG, El Nakib, M, Jurjus, AR. Knowledge, attitudes, beliefs and practices in Lebanon concerning HIV/AIDS, 1996–2004. East Mediterr Health J [Internet]. 2009 [cited 2025 May 14];15(4). Available from: https://www.emro.who.int/emhj-volume-15-2009/volume-15-issue-4/knowledge-attitudes-beliefs-and-practices-in-lebanon-concerning-hivaids-19962004.html

     

    21.        HIV Undetectable=Untransmittable (U=U), or Treatment as Prevention | NIAID: National Institute of Allergy and Infectious Diseases. May 21, 2019. Accessed May 14, 2025. https://www.niaid.nih.gov/diseases-conditions/treatment-prevention

    22.        Shin SJ, Vail RM, Shah SS, et al. Perioperative Care in Adults With HIV. Johns Hopkins University; 2024. Accessed December 22, 2025. http://www.ncbi.nlm.nih.gov/books/NBK576018/

    23.        Post-Exposure Prophylaxis (PEP) | NIH. Accessed May 14, 2025. https://hivinfo.nih.gov/understanding-hiv/fact-sheets/post-exposure-prophylaxis-pep

    24.        Lambert B. AIDS WAR SHUNNED BY MANY DOCTORS. The New York Times. https://www.nytimes.com/1990/04/23/nyregion/aids-war-shunned-by-many-doctors.html. April 23, 1990. Accessed May 14, 2025.

    25.        Cunningham CT, Quan H, Hemmelgarn B, Noseworthy T, Beck CA, Dixon E, et al. Exploring physician specialist response rates to web-based surveys. BMC Med Res Methodol. 2015 Apr 9;15(1):32. https://doi.org/10.1186/s12874-015-0016-z

     

    26.        de Koning R, Egiz A, Kotecha J, Ciuculete AC, Ooi SZY, Bankole NDA, et al. Survey Fatigue During the COVID-19 Pandemic: An Analysis of Neurosurgery Survey Response Rates. Front Surg. 2021;8:690680. https://doi.org/10.3389/fsurg.2021.690680

     

    27.        Peabody JW, Taguiwalo MM, Robalino DA, Frenk J. Improving the quality of care in developing countries. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., editors. Disease Control Priorities in Developing Countries [Internet]. New York: Oxford University Press; 2006. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21250362

     

    28.        Booker QS, Austin JD, Balasubramanian BA. Survey strategies to increase participant response rates in primary care research studies. Family Practice. 2021;38(5):699–702. https://doi.org/10.1093/fampra/cmab070

     

Latest articles

Loading articles...

Indexing Information

Loading...

PoEM News

Loading news...

Partnership

Loading...

Journal Metrics

Loading...

Meet the Board

Support for Authors

1

Getting Started

Register with journal and receive Author role. Access dashboard to begin new submission.
2

Complete Submission

Select language, title, section • Enter abstract, keywords, references • Upload files • Add co-authors
3

Review & Submit

Add optional comments for editors and suggest reviewers. Review all information and confirm submission.

Submitted

Your submission is complete and under review

Published

Article successfully published
8

Copyediting

Review copyedited files and publication-ready versions. Provide feedback or approval through discussions.
7

Acceptance

Accepted manuscripts proceed to copyediting and production. Receive confirmation notifications.
6

Upload Revised

Upload revised files through Review tab with response to reviewers (if revisions required).
5

Peer Review

Receive editor's decision via email and dashboard.
4

Track Submission

Monitor submission status via Author Dashboard.

Support for Reviewers

1

Receive Invitation

Editors send invitation via email with manuscript details. Access via link or journal login.
2

Request Details

Click to access assignment details including article title, abstract, review files, and schedule.
3

Accept / Decline

Review submission details and privacy statement. Decide whether to accept or decline the assignment.
4

Read Guidelines

Review journal's specific reviewer guidelines. Guidelines remain accessible throughout the review process.
5

Review Manuscript

Download review files and conduct thorough review. Enter comments for editor and author.

Complete

Review successfully submitted
9

Submit Review

When satisfied with review and recommendation click Submit. Confirm submission to complete the process.
8

Communicate

Use Review Discussion panel to ask questions. Click Add discussion to start conversation.
7

Recommendation

Select recommendation from dropdown menu based on review: Accept, Revisions, Resubmit, or Decline.
6

Upload Files

Optionally upload marked-up copy of review file. Remember to anonymize if required by type.
PoEM Footer